image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
64f7365cb122b37c07a7451ac42c2e4cb34a50ee0eef6c91ea99a652cc33c18e.png | simple | <table><tr><td>Project and Timeline</td><td>General Objective</td><td>Study Sites</td><td>Consortium partners</td></tr><tr><td>CERCA1/03/10 –29/02/14</td><td>To contribute to global knowledge about how health systems can be more responsive to the sexual and reproductive health needs of adolescents and, by extensi... | <table><tr><td>Project and Timeline</td><td>General Objective</td><td>Study Sites</td><td>Consortium partners</td></tr><tr><td>CERCA1/03/10 –29/02/14</td><td>To contribute to global knowledge about how health systems can be more responsive to the sexual and reproductive health needs of adolescents and, by extension, to... | <table><tr><td>Project and Timeline</td><td>General Objective</td><td>Study Sites</td><td>Consortium partners</td></tr><tr><td>MOMI1/02/11 –31/01/16</td><td>To improve maternal and newborn health through a focus on the postpartum period, adopting context-specific strategies to strengthen health care delivery and servic... |
9edc76fb06eec73be254b10fce7d0b72e5a8cce5a08e38587da746c61f579add.png | simple | <table><tr><td>Characteristics</td><td>Number of patients (%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>107 (81.7)</td></tr><tr><td>Female</td><td>24 (18.3)</td></tr><tr><td>Age</td><td></td></tr><tr><td>≤64</td><td>57 (43.5)</td></tr><tr><td>>64</td><td>74 (56.5)</td></tr><tr><td>Smoking</td... | <table><tr><td>Characteristics</td><td>Number of patients (%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>107 (81.7)</td></tr><tr><td>Female</td><td>24 (18.3)</td></tr><tr><td>Age</td><td></td></tr><tr><td>≤64</td><td>57 (43.5)</td></tr><tr><td>>64</td><td>74 (56.5)</td></tr><tr><td>Smoking</td><td></td... | <table><tr><td>Characteristics</td><td>Number of patients (%)</td></tr><tr><td>Grade</td><td></td></tr><tr><td>Low</td><td>60 (45.8)</td></tr><tr><td>High</td><td>71 (54.2)</td></tr><tr><td>Invasiveness</td><td></td></tr><tr><td>Muscle-invasive</td><td>72 (55.0)</td></tr><tr><td>Non-muscle-invasive</td><td>59 (45.0)</t... |
20a3e272e7ba2ad6914e590d51431b18bbcd28297d55c29bae2eebbb167e6f92.png | complex | <table><tr><td>Characteristics</td><td>All patients(<i>n</i> = 188)</td><td>Nafcillin group(<i>n</i> = 91)</td><td>Glycopeptide group(<i>n</i> = 97)</td><td><i>P</i> value</td></tr><tr><td>Age, years, mean ± SD</td><td>62.37 ± 15.14</td><td>64.38 ± 14.53</td><td>60.46 ± 15.54</td><td>0.076 <sup>a</s... | <table><tr><td>Characteristics</td><td>All patients(n = 188)</td><td>Nafcillin group(n = 91)</td><td>Glycopeptide group(n = 97)</td><td>P value</td></tr><tr><td>Age, years, mean ± SD</td><td>62.37 ± 15.14</td><td>64.38 ± 14.53</td><td>60.46 ± 15.54</td><td>0.076 a</td></tr><tr><td>Male, (%)</td><td>129 (69.0)</td><td>6... | <table><tr><td>Chronic kidney disease</td><td>39 (20.7)</td><td>23 (25.3)</td><td>16 (16.5)</td><td>0.153 b</td></tr><tr><td>Diabetes</td><td>62 (33.0)</td><td>35 (38.5)</td><td>27 (27.8)</td><td>0.162 b</td></tr><tr><td>Liver disease</td><td>23 (12.2)</td><td>8 (8.8)</td><td>15 (15.5)</td><td>0.187 b</td></tr><tr><td>... |
69b44706b64364cca8e5045717597e1f68c23e1fc283c89bec879bfa2acec7c2.png | simple | <table><tr><td></td><td>Gene</td><td>Alteration</td><td>RsID</td><td>COSMIC</td></tr><tr><td>Sample 1</td><td>ARID1A</td><td>Gln1614*</td><td>NR</td><td>NR</td></tr><tr><td>Sample 1</td><td>NOTCH1</td><td>N280S</td><td>rs367825691</td><td>NR</td></tr><tr><td>Sample 1</td><td>PIK3CA</td><td>EDLLNPI453del</td><td>NR</td>... | <table><tr><td></td><td>Gene</td><td>Alteration</td><td>RsID</td><td>COSMIC</td></tr><tr><td>Sample 1</td><td>ARID1A</td><td>Gln1614*</td><td>NR</td><td>NR</td></tr><tr><td>Sample 1</td><td>NOTCH1</td><td>N280S</td><td>rs367825691</td><td>NR</td></tr><tr><td>Sample 1</td><td>PIK3CA</td><td>EDLLNPI453del</td><td>NR</td>... | <table><tr><td></td><td>Gene</td><td>Alteration</td><td>RsID</td><td>COSMIC</td></tr><tr><td>Sample 2</td><td>ARID1A</td><td>Leu1054Phe</td><td>NR</td><td>NR</td></tr><tr><td>Sample 2</td><td>KMT2D</td><td>Gln3745dup</td><td>rs775492040</td><td>NR</td></tr><tr><td>Sample 3</td><td>CDKN2Aa</td><td>Glu69*</td><td>rs12191... |
abc51710d20ddd90035f38b3ef3b8ff692500dbaa436702fe3dd9ed61b9f0376.png | complex | <table><tr><td></td><td>Native</td><td>Derivative</td></tr><tr><td colspan="3">Data collection</td></tr><tr><td> Beamline</td><td>ESRF ID14-4</td><td>SLS X06DA (PXIII)</td></tr><tr><td> Spacegroup</td><td>P3</td><td>P3</td></tr><tr><td> Unit cell parameters (Å, °)</td><td>a = b = 104.50, c = 33.59</td><td>a ... | <table><tr><td></td><td>Native</td><td>Derivative</td></tr><tr><td colspan="3">Data collection</td></tr><tr><td>Beamline</td><td>ESRF ID14-4</td><td>SLS X06DA (PXIII)</td></tr><tr><td>Spacegroup</td><td>P3</td><td>P3</td></tr></table> | <table><tr><td></td><td>Native</td><td>Derivative</td></tr><tr><td>Unit cell parameters (Å, °)</td><td>a = b = 104.50, c = 33.59</td><td>a = b = 104.03, c = 33.56</td></tr><tr><td></td><td>α = β = 90, γ = 120</td><td>α = β = 90, γ = 120</td></tr><tr><td>Wavelength (Å)</td><td>0.91970</td><td>0.97942</td></tr><tr><td>... |
a0117e3bec88af94a50c4f34370fa3cdfab3e7baf8e0e939f7ed83e431e3465d.png | simple | <table><tr><td>Genetics</td><td>Mechanism</td><td>Incidence</td><td>Reference</td></tr><tr><td><i>Ptch</i>+/−</td><td>Conventional KO</td><td>14%–19% by 10 months</td><td>(23, 44, 98)</td></tr><tr><td><i>Ptch</i>+/−</td><td>Conventional KO; irradiation</td><td>100% by 10 months</td><td>(54, 55)</td></... | <table><tr><td>Genetics</td><td>Mechanism</td><td>Incidence</td><td>Reference</td></tr><tr><td>Ptch+/−</td><td>Conventional KO</td><td>14%–19% by 10 months</td><td>(23, 44, 98)</td></tr><tr><td>Ptch+/−</td><td>Conventional KO; irradiation</td><td>100% by 10 months</td><td>(54, 55)</td></tr><tr><td>Ptch+/−; p53−/−</td><... | <table><tr><td>Genetics</td><td>Mechanism</td><td>Incidence</td><td>Reference</td></tr><tr><td>; n-myc</td><td>AS</td><td>hs</td><td>7)</td></tr><tr><td>Shh; Bcl-2</td><td>RCAS</td><td>78% by 3 months</td><td>(49)</td></tr><tr><td>Rb±/−; p53−/−</td><td>Conditional KO (GFAP-Cre)</td><td>25%–100% by 2–7 months</td><td>(4... |
15cdaa8ec653d8e806bd0f223df35602b3cc5d1482898fdb119a56f9752d2663.png | complex | <table><tr><td>Input variables</td><td>Unit cost (£)</td><td>Source</td><td>Details</td></tr><tr><td colspan="4">Interventions</td></tr><tr><td> Lens extraction implemented as day case</td><td>866</td><td>National schedule of reference costs year 2012–2013</td><td>Phacoemulsification cataract extraction and ... | <table><tr><td>Input variables</td><td>Unit cost (£)</td><td>Source</td><td>Details</td></tr><tr><td colspan="4">Interventions</td></tr><tr><td>Lens extr</td><td></td><td>Nati</td><td>Phacoemulsification cataract extraction and </td></tr></table> | <table><tr><td>Input variables</td><td>Unit cost (£)</td><td>Source</td><td>Details</td></tr><tr><td>action implemented as day case</td><td>866</td><td>onal schedule of reference costs year 2012–2013</td><td>lens implant implemented as day case (BZ02)</td></tr><tr><td>Lens extraction implemented as inpatient</td><td>21... |
6f81e5e5acfa77f8f4396fa331e817f4b03284e33a8071038404eb4b324db8fa.png | simple | <table><tr><td>Variable</td><td>Beta</td><td>Standard error</td><td>Significance (p value)</td></tr><tr><td><i>toeC</i></td><td>−0.197</td><td>0.058</td><td>0.001</td></tr><tr><td><i>lead + 1</i></td><td>0.060</td><td>0.018</td><td>0.001</td></tr><tr><td><i>toeP-maxE</i></td><td>−0.010</td><td>0.004</td><td... | <table><tr><td>Variable</td><td>Beta</td><td>Standard error</td><td>Significance (p value)</td></tr><tr><td>toeC</td><td>−0.197</td><td>0.058</td><td>0.001</td></tr></table> | <table><tr><td>lead + 1</td><td>0.060</td><td>0.018</td><td>0.001</td></tr><tr><td>toeP-maxE</td><td>−0.010</td><td>0.004</td><td>0.014</td></tr><tr><td>kneeF</td><td>−0.349</td><td>0.107</td><td>0.001</td></tr><tr><td>heelC</td><td>0.123</td><td>0.047</td><td>0.009</td></tr></table> |
a576abb215c237709f502abf3ba10fb7757c44ac8f7a638d5dd351eb32fae8c0.png | simple | <table><tr><td> </td><td>Total (<i>n =</i> 149)</td></tr><tr><td>Mean age ± SD, range</td><td>38.95 ± 11.48, 20-77</td></tr><tr><td>Years in the US ± SD</td><td>10.24 ± 10.12</td></tr><tr><td>Years in Baltimore ± SD</td><td>7.56 ± 9.09</td></tr><tr><td>Gender</td><td> </td></tr><tr><td>Fem... | <table><tr><td></td></tr><tr><td>Mean age ± SD, range</td></tr><tr><td>Years in the US ± SD</td></tr><tr><td>Years in Baltimore ± SD</td></tr><tr><td>Gender</td></tr><tr><td>Female</td></tr><tr><td>Male</td></tr><tr><td>Latin American Region</td></tr><tr><td>Mexican</td></tr><tr><td>Central American</td></tr><tr><td>So... | <table><tr><td>Total (n = 149)</td></tr><tr><td>38.95 ± 11.48, 20-77</td></tr><tr><td>10.24 ± 10.12</td></tr><tr><td>7.56 ± 9.09</td></tr><tr><td></td></tr><tr><td>(98) 65.7%</td></tr><tr><td>(51) 34.3%</td></tr><tr><td></td></tr><tr><td>(38) 25.5%</td></tr><tr><td>(87) 58.4%</td></tr><tr><td>(24) 16.1%</td></tr><tr><t... |
35fe0e2ed9ef0990ba10c47dac8e3290f519ed8e6c2832b98e9b0edaa47b09c5.png | simple | <table><tr><td>Substance</td><td>No. of cases</td><td>Percentage</td></tr><tr><td>Hydrofluoric acid</td><td>135</td><td>27.44</td></tr><tr><td>Sulfuric acid</td><td>115</td><td>23.37</td></tr><tr><td>Mixed acid</td><td>41</td><td>8.33</td></tr><tr><td>Sodium (potassium) hydroxide</td><td>33</td><td>6.71</td></tr><tr><t... | <table><tr><td>Substance</td><td>No. of cases</td></tr><tr><td>Hydrofluoric acid</td><td>135</td></tr><tr><td>Sulfuric acid</td><td>115</td></tr><tr><td>Mixed acid</td><td>41</td></tr><tr><td>Sodium (potassium) hydroxide</td><td>33</td></tr><tr><td>Nitric acid</td><td>31</td></tr><tr><td>Hydrochloric acid</td><td>27</t... | <table><tr><td>Percentage</td></tr><tr><td>27.44</td></tr><tr><td>23.37</td></tr><tr><td>8.33</td></tr><tr><td>6.71</td></tr><tr><td>6.30</td></tr><tr><td>5.49</td></tr><tr><td>3.66</td></tr><tr><td>2.85</td></tr><tr><td>2.24</td></tr><tr><td>2.03</td></tr><tr><td>1.63</td></tr><tr><td>1.42</td></tr><tr><td>1.42</td></... |
dc3d9f8e981e71558d44a9fc9f70ff5b5b020249d333400bc23279604d9a9433.png | complex | <table><tr><td></td><td colspan="2">Total Group (<i>n</i> = 1526) <sup>1</sup></td><td colspan="2">10–11 Months (<i>n</i> = 31)</td><td colspan="2">1 Year (<i>n</i> = 411)</td><td colspan="2">2 Years (<i>n</i> = 497)</td><td colspan="2">3 Years (<i>n</i> = 410)</td></tr><tr><td>Food Group</td><td>Mean</td><td>SD<... | <table><tr><td></td><td colspan="2">Total Group (n = 1526) 1</td><td colspan="2">10–11 Months (n = 31)</td><td colspan="2">1 Year (n = 411)</td></tr><tr><td>Food Group</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>Potatoes</td><td>29</td><td>27</td><td>25</td><td>25</td><td>31... | <table><tr><td colspan="2">2 Years (n = 497)</td><td colspan="2">3 Years (n = 410)</td></tr><tr><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>28</td><td>27</td><td>28</td><td>26</td></tr><tr><td>58</td><td>39</td><td>61</td><td>38</td></tr><tr><td>129</td><td>59</td><td>130</td><td>61</td></tr><tr><td>1<... |
b868c3fb20e63802393409c1481298bf8077a676cc8953c25c3741a4255260e8.png | simple | <table><tr><td>Variable</td><td> </td></tr><tr><td>Sex [no. (%)] n = 634</td><td> </td></tr><tr><td>Female</td><td>388 (61.2)</td></tr><tr><td>Age [mean: years (SD)] n = 634</td><td>56.30 (13.95)</td></tr><tr><td>Nationality [no. (%)] n = 619</td><td> </td></tr><tr><td>German</td><td>610 (98.5)</td></tr><tr><td>Other</... | <table><tr><td>Variable</td></tr><tr><td>Sex [no. (%)] n = 634</td></tr><tr><td>Female</td></tr><tr><td>Age [mean: years (SD)] n = 634</td></tr><tr><td>Nationality [no. (%)] n = 619</td></tr><tr><td>German</td></tr><tr><td>Other</td></tr><tr><td>Marital status [no. (%)] n = 634</td></tr><tr><td>Single</td></tr><tr><td>... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>388 (61.2)</td></tr><tr><td>56.30 (13.95)</td></tr><tr><td></td></tr><tr><td>610 (98.5)</td></tr><tr><td>9 (1.5)</td></tr><tr><td></td></tr><tr><td>82 (12.9)</td></tr><tr><td>415 (65.5)</td></tr><tr><td>80 (12.6)</td></tr><tr><td>57 (9.0)</td></tr><tr><td>477 (78.1)</t... |
960fac7e435cae92679a053dadc864faca2dad594c56fd272aaea1873b18561e.png | simple | <table><tr><td>Group</td><td>No of cases<sup>a</sup>(Females)</td><td>Age (years) median; 80% CR<sup>b</sup></td><td>Marsh grade span</td><td>Anti-TG2 (U/mL)<sup>c</sup>median; 80% CR</td><td>Anti-DGP (U/mL)<sup>d</sup>median; 80% CR</td><td>Anti-GL (U/mL)<sup>e</sup>median; 80% CR</td></tr><tr><td>Not CD</td><td>14 (8... | <table><tr><td>Group</td><td>No of casesa(Females)</td><td>Age (years) median; 80% CRb</td><td>Marsh grade span</td><td>Anti-TG2 (U/mL)cmedian; 80% CR</td><td>Anti-DGP (U/mL)dmedian; 80% CR</td><td>Anti-GL (U/mL)emedian; 80% CR</td></tr><tr><td>Not CD</td><td>14 (8)</td><td>8.8; 2.2-16</td><td>Marsh 0-1</td><td>0.25; 0... | <table><tr><td>Group</td><td>No of casesa(Females)</td><td>Age (years) median; 80% CRb</td><td>Marsh grade span</td><td>Anti-TG2 (U/mL)cmedian; 80% CR</td><td>Anti-DGP (U/mL)dmedian; 80% CR</td><td>Anti-GL (U/mL)emedian; 80% CR</td></tr><tr><td>Active CDg</td><td>20 (12)</td><td>5.9; 1.5-14</td><td>Marsh 2-3C</td><td>2... |
509cd8d19f1957c726bbcc55644be0cfe073beaf2ac6ed6d6c42c5a0101e91fe.png | complex | <table><tr><td>Sample Name</td><td colspan="2">N-Call stretch lengths (bp)</td><td>Mutation found by conventional sequencing</td></tr><tr><td></td><td>*GSEQ</td><td>*sPROFILER</td><td></td></tr><tr><td>mtDNA1</td><td>5, 6, 9, 13</td><td>4, 5</td><td>1 point mutation (in 5 base stretch)</td></tr><tr><td>mtDNA2</td><td>5... | <table><tr><td>Sample Name</td><td colspan="2">N-Call stretch lengths (bp)</td><td>Mutation found by conventional sequencing</td></tr></table> | <table><tr><td></td><td>*GSEQ</td><td>*sPROFILER</td><td></td></tr><tr><td>mtDNA1</td><td>5, 6, 9, 13</td><td>4, 5</td><td>1 point mutation (in 5 base stretch)</td></tr><tr><td>mtDNA2</td><td>5, 6, 12</td><td>4, 5, 6</td><td>1 point mutation (in 6 base stretch)</td></tr><tr><td>mtDNA3</td><td>5, 6, 7, 11</td><td>4, 10<... |
a0a2f215ba82374aa366c246b3e0edbe83365baf4da49eefa7debf370105ce26.png | simple | <table><tr><td>Country</td><td>VTE patients %</td><td>General healthy population %</td><td>References</td></tr><tr><td>Lebanon</td><td>19.2</td><td>1.3–3.6</td><td>94–99</td></tr><tr><td>Palestine</td><td>---</td><td>6.5–11.7</td><td>74,100</td></tr><tr><td>Egypt</td><td>23.75</td><td>3.33</td><td>101... | <table><tr><td>Country</td><td>VTE patients %</td><td>General healthy population %</td><td>References</td></tr><tr><td>Lebanon</td><td>19.2</td><td>1.3–3.6</td><td>94–99</td></tr><tr><td>Palestine</td><td>---</td><td>6.5–11.7</td><td>74,100</td></tr><tr><td>Egypt</td><td>23.75</td><td>3.33</td><td>101</td></tr><tr><td>... | <table><tr><td>Country</td><td>VTE patients %</td><td>General healthy population %</td><td>References</td></tr><tr><td>eria</td><td>.0</td><td>1.8</td><td>06</td></tr><tr><td>Morocco</td><td>---</td><td>2.4–5.5</td><td>74,107–109</td></tr><tr><td>Spain</td><td>2.7–17.2</td><td>2.9–6.5</td><td>31–35</td></tr><tr><td>Fra... |
1b6ca2e06f264e23841ff8a91305e3a7a4761eb067dfe796bca7b8b14166cc19.png | complex | <table><tr><td colspan="2"></td><td colspan="6">Serum resistin level (ng/ml)</td></tr><tr><td colspan="2"></td><td>1.5-6.7</td><td>6.8-8.7</td><td>8.8-11.5</td><td>11.6-16.2</td><td>16.3-90.2</td><td>P value for trend</td></tr><tr><td colspan="2">No cardiovascular disease, n</td><td>628</td><td>610</td><td>604</td><td>... | <table><tr><td colspan="2"></td><td colspan="6">Serum resistin level (ng/ml)</td></tr><tr><td colspan="2"></td><td>1.5-6.7</td><td>6.8-8.7</td><td>8.8-11.5</td><td>11.6-16.2</td><td>16.3-90.2</td><td>P value for trend</td></tr><tr><td colspan="2">No cardiovascular disease, n</td><td>628</td><td>610</td><td>604</td><td>... | <table><tr><td colspan="2">Model 1-adjusted OR (95% CI)</td><td>1(referent)</td><td>0.55(0.19-1.57)</td><td>1.13(0.47-2.73)</td><td>0.88(0.36-2.18)</td><td>1.11(0.48-2.59)</td><td>0.48</td></tr><tr><td colspan="2">Model 2-adjusted OR (95% CI)</td><td>1(referent)</td><td>0.48(0.16-1.41)</td><td>1.20(0.49-2.95)</td><td>0... |
c5dc93881ef83de0b8acb194b132971c89c49c026bd65f592397ab3a548d13ed.png | simple | <table><tr><td>Spot No.</td><td>Protein Identity</td><td>Symbol</td><td>MW (kDa)</td></tr><tr><td>1</td><td>Aldehyde dehydrogenase,mitochondrial precursor</td><td>Aldh2</td><td>56</td></tr><tr><td>2</td><td>Protein disulfide-isomerase A3precursor</td><td>Pdia3/ERP57</td><td>57</td></tr><tr><td>3</td><td>Proteasome subu... | <table><tr><td>Spot No.</td><td>Protein Identity</td><td>Symbol</td><td>MW (kDa)</td></tr><tr><td>1</td><td>Aldehyde dehydrogenase,mitochondrial precursor</td><td>Aldh2</td><td>56</td></tr><tr><td>2</td><td>Protein disulfide-isomerase A3precursor</td><td>Pdia3/ERP57</td><td>57</td></tr><tr><td>3</td><td>Proteasome subu... | <table><tr><td>Spot No.</td><td>Protein Identity</td><td>Symbol</td><td>MW (kDa)</td></tr><tr><td>4</td><td>idyl-prolyl cis-transisomerase A</td><td>/CYPA</td><td>7</td></tr></table> |
9d8bcce936a4994a02242c02a52e425ad9532d8d473c1cd327ea8f4f26a4403c.png | complex | <table><tr><td></td><td colspan="3">DMC</td><td colspan="3">DMR</td><td colspan="3">CG</td></tr><tr><td></td><td>CN</td><td>SPE</td><td>MNE</td><td>CN</td><td>SPE</td><td>MNE</td><td>CN</td><td>SPE</td><td>MNE</td></tr><tr><td>Proposed</td><td>5,593.9</td><td>0.958</td><td>0.039</td><td>5,305.3</td><td>0.939</td><td>0.... | <table><tr><td></td><td colspan="3">DMC</td><td colspan="3">DMR</td><td colspan="3">CG</td></tr><tr><td></td><td>CN</td><td>SPE</td><td>MNE</td><td>CN</td><td>SPE</td><td>MNE</td><td>CN</td><td>SPE</td><td>MNE</td></tr><tr><td>Proposed</td><td>5,593.9</td><td>0.958</td><td>0.039</td><td>5,305.3</td><td>0.939</td><td>0.... | <table><tr><td></td><td colspan="3">DMC</td><td colspan="3">DMR</td><td colspan="3">CG</td></tr><tr><td></td><td>CN</td><td>SPE</td><td>MNE</td><td>CN</td><td>SPE</td><td>MNE</td><td>CN</td><td>SPE</td><td>MNE</td></tr><tr><td>PINALOG</td><td>3,779</td><td>0.726</td><td>0.274</td><td>3,533.4</td><td>0.683</td><td>0.317... |
02e8dd5116db6e8915188a38b4a83f464636baceb554bd46060513829a0f8c14.png | complex | <table><tr><td rowspan="2">Line</td><td rowspan="2">Wt (g)</td><td colspan="2">Temperature measures</td><td colspan="2">Observation measures</td><td rowspan="2">SqX</td><td rowspan="2">Rise</td><td rowspan="2">SG</td><td rowspan="2">TIS</td><td rowspan="2">D/U</td></tr><tr><td>Preax (°C)</td><td>Postax (°C)</... | <table><tr><td rowspan="2">Line</td><td rowspan="2">Wt (g)</td><td>Temperature measures</td></tr><tr><td>Preax (°C)</td></tr><tr><td>High</td><td>19.6</td><td>35.2</td></tr><tr><td>SEM</td><td>0.83</td><td>0.35</td></tr><tr><td>Rand</td><td>22.1</td><td>36.1</td></tr><tr><td>SEM</td><td>0.9</td><td>0.13</td></tr><tr><t... | <table><tr><td>Temperature measures</td><td colspan="2">Observation measures</td><td rowspan="2">SqX</td><td rowspan="2">Rise</td><td rowspan="2">SG</td><td rowspan="2">TIS</td><td rowspan="2">D/U</td></tr><tr><td>Postax (°C)</td><td>Preamb (°C)</td><td>Postamb (°C)</td></tr><tr><td>33.8</td><td>21.3</td><td>21.5</td><... |
decd374c62d1c5983d0edf479d8be24cf3b3f40258ce64ecec3df83f7b485575.png | simple | <table><tr><td>Criteria</td><td>Conventional</td><td>Sutureless</td></tr><tr><td>Operation duration</td><td>Longer</td><td>Shorter</td></tr><tr><td>Blood less during operation</td><td>More probable</td><td>Less probable</td></tr><tr><td>Safe and reliable</td><td>Less probable</td><td>More probable</td></tr><tr><td>Resi... | <table><tr><td>Criteria</td><td>Conventional</td><td>Sutureless</td></tr><tr><td>Operation duration</td><td>Longer</td><td>Shorter</td></tr></table> | <table><tr><td>Blood less during operation</td><td>More probable</td><td>Less probable</td></tr><tr><td>Safe and reliable</td><td>Less probable</td><td>More probable</td></tr><tr><td>Resistance of anastomosis (mechanical and pressure testing)</td><td>Less probable</td><td>More probable</td></tr><tr><td>Operative and po... |
b7645552301878c80fba5de6539ed830b3e9b19aa8f776ff1d6965955833ae8b.png | complex | <table><tr><td rowspan="2">Institution</td><td colspan="7">Checklists</td></tr><tr><td>Step 1</td><td>Step 2</td><td>Step 3</td><td>Step 4</td><td>Step 5</td><td>Step 6</td><td>Step 7</td></tr><tr><td>A</td><td></td><td></td><td>4</td><td>1</td><td></td><td>2</td><td>2</td></tr><tr><td>B</td><td></td><td></td><td>3</td... | <table><tr><td rowspan="2">Institution</td><td colspan="7">Checklists</td></tr><tr><td>Step 1</td><td>Step 2</td><td>Step 3</td><td>Step 4</td><td>Step 5</td><td>Step 6</td><td>Step 7</td></tr><tr><td>A</td><td></td><td></td><td>4</td><td>1</td><td></td><td>2</td><td>2</td></tr><tr><td>B</td><td></td><td></td><td>3</td... | <table><tr><td rowspan="2">Institution</td><td colspan="7">Checklists</td></tr><tr><td>Step 1</td><td>Step 2</td><td>Step 3</td><td>Step 4</td><td>Step 5</td><td>Step 6</td><td>Step 7</td></tr><tr><td>F</td><td></td><td></td><td></td><td></td><td></td><td></td><td>3</td></tr><tr><td>G</td><td>2</td><td>2</td><td>2</td>... |
feb992b9f9f6bb39e5c42070223eac5493b301b5a8701ee35a8094eb6a299779.png | complex | <table><tr><td rowspan="3">No</td><td rowspan="3">Preparation</td><td rowspan="3">Dosage from</td><td rowspan="3">Trade name / Manufacturer</td><td colspan="2">Dissolution time (mins, n=3)</td></tr><tr><td>pH 1.2</td><td>pH 5.8</td></tr><tr><td>1</td><td>Ferrous sulphate</td><td>Tablet</td><td>NAAlmus</td><td>48 ±... | <table><tr><td>No</td><td>Preparation</td><td>Dosage from</td><td>Trade name / Manufacturer</td><td colspan="2">Dissolution time (mins, n=3)</td></tr></table> | <table><tr><td rowspan="2">No</td><td rowspan="2">Preparation</td><td rowspan="2">Dosage from</td><td rowspan="2">Trade name / Manufacturer</td><td>pH 1.2</td><td>pH 5.8</td></tr><tr><td colspan="2"></td></tr><tr><td>1</td><td>Ferrous sulphate</td><td>Tablet</td><td>NAAlmus</td><td>48 ± 4</td><td>362 ± 16</td></tr><tr>... |
204c25fcfd6c9c3bc896b6f22797f06914066afe33f4b6b7057a2a5065f5de07.png | complex | <table><tr><td></td><td colspan="2">Multiple Sexual Partners</td><td colspan="2">Paying Sex</td></tr><tr><td></td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td></tr><tr><td>Used condom</td><td>384</td><td>33.9</td><td>469</td><td>58.5</td></tr><tr><td>Did not use condom</td><td>748</td><td>66.1</td><td>333</td>... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>Used condom</td></tr><tr><td>Did not use condom</td></tr></table> | <table><tr><td colspan="2">Multiple Sexual Partners</td><td colspan="2">Paying Sex</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>384</td><td>33.9</td><td>469</td><td>58.5</td></tr><tr><td>748</td><td>66.1</td><td>333</td><td>41.5</td></tr></table> |
5b7804314b5d8208602f414d3b780117778b902555a2897da163b14b22b2c7a5.png | simple | <table><tr><td>miRNA</td><td>Fold change (cytokine versus normal group)</td><td><i>p</i> value</td></tr><tr><td>hsa-miR-665</td><td>4.64</td><td>0.01</td></tr><tr><td>hsa-miR-146b-5p</td><td>4.13</td><td>0.04</td></tr><tr><td>hsa-miR-155-5p</td><td>4.00</td><td><0.01</td></tr><tr><td>hsa-miR-19b-3p</td><td>2.10</td>... | <table><tr><td>miRNA</td><td>Fold change (cytokine versus normal group)</td><td>p value</td></tr><tr><td>hsa-miR-665</td><td>4.64</td><td>0.01</td></tr><tr><td>hsa-miR-146b-5p</td><td>4.13</td><td>0.04</td></tr><tr><td>hsa-miR-155-5p</td><td>4.00</td><td><0.01</td></tr><tr><td>hsa-miR-19b-3p</td><td>2.10</td><td>0.01</... | <table><tr><td>miRNA</td><td>Fold change (cytokine versus normal group)</td><td>p value</td></tr><tr><td>4497</td><td></td><td>2</td></tr><tr><td>hsa-miR-4732-5p</td><td>0.40</td><td>0.02</td></tr><tr><td>hsa-miR-4640-5p</td><td>0.34</td><td>0.02</td></tr><tr><td>hsa-miR-6886-5p</td><td>0.33</td><td>0.02</td></tr><tr><... |
b38e725856be3a5755053b547865ec0a45f8d3a5c30c1002d18d6ae9f9e43b51.png | complex | <table><tr><td colspan="2">Items</td><td>1) Basic science content objectives were made clear to students</td><td>2) Basic science content was sufficiently integrated across basic science courses</td><td>3) Basic science content objectives and examination content matched closely</td><td>4) Basic science content had suff... | <table><tr><td>Items</td></tr><tr><td rowspan="2">% of agree</td></tr><tr></tr><tr><td rowspan="2">TC</td></tr><tr></tr><tr><td rowspan="2">RC</td></tr><tr></tr><tr><td>U (p)</td></tr><tr><td>Cohen’s d</td></tr></table> | <table><tr><td>Items</td><td>1) Basic science content objectives were made clear to students</td><td>2) Basic science content was sufficiently integrated across basic science courses</td><td>3) Basic science content objectives and examination content matched closely</td><td>4) Basic science content had sufficient illus... |
c27f8014415d9781fbb792904b7d10a276188019d992ae8328a4e8a7d9bb83b0.png | simple | <table><tr><td>Reported Adverse event</td><td>No of related AEs (no. of patients)</td><td>CTCAE-grade (range)</td></tr><tr><td>Fever</td><td>8 (5)</td><td>1–2</td></tr><tr><td>Chills</td><td>2 (2)</td><td>1</td></tr><tr><td>Rash</td><td>1 (1)</td><td>1</td></tr><tr><td>Hypotension</td><td>1 (1)</td><td>2</td></tr... | <table><tr><td>Reported Adverse event</td><td>No of related AEs (no. of patients)</td><td>CTCAE-grade (range)</td></tr><tr><td>Fever</td><td>8 (5)</td><td>1–2</td></tr></table> | <table><tr><td>Reported Adverse event</td><td>No of related AEs (no. of patients)</td><td>CTCAE-grade (range)</td></tr><tr><td>Chills</td><td>2 (2)</td><td>1</td></tr><tr><td>Rash</td><td>1 (1)</td><td>1</td></tr><tr><td>Hypotension</td><td>1 (1)</td><td>2</td></tr></table> |
fc45aa23dab0719736cbc0b336f05ab29bce004df6c1b7e7a8e105c0559d65ea.png | complex | <table><tr><td> </td><td colspan="3">+20% Fat group (<i>N</i> = 14)</td><td colspan="3">−20% Fat group (<i>N</i> = 17)</td></tr><tr><td> </td><td>Pre</td><td>Post</td><td><i>P</i> value</td><td>Pre</td><td>Post</td><td><i>P</i> value</td></tr><tr><td>Height (m)</td><td>1.76 ± 0.01</td><td>1.76 ± 0.01</t... | <table><tr><td></td><td colspan="3">+20% Fat group (N = 14)</td><td colspan="3">−20% Fat group (N = 17)</td></tr><tr><td></td><td>Pre</td><td>Post</td><td>P value</td><td>Pre</td><td>Post</td><td>P value</td></tr><tr><td>Height (m)</td><td>1.76 ± 0.01</td><td>1.76 ± 0.01</td><td>—</td><td>1.74 ± 0.02</td><td>1.74 ± 0.0... | <table><tr><td></td><td colspan="3">+20% Fat group (N = 14)</td><td colspan="3">−20% Fat group (N = 17)</td></tr><tr><td></td><td>Pre</td><td>Post</td><td>P value</td><td>Pre</td><td>Post</td><td>P value</td></tr><tr><td>Mass (kg)</td><td>78.1 ± 2.7</td><td>78.0 ± 3.0</td><td>.665</td><td>65.8 ± 2.4</td><td>66.7 ± 2.4<... |
c76e603f641921e939c0a1d1f324a3601e58eafd0362a5d6e387ebf5d504e370.png | simple | <table><tr><td><i>No.</i></td><td><i>Gene ID</i></td><td>P<i>-value</i></td><td><i>Fold difference (sensitive vs resistant)</i></td><td><i>Fold difference (description)</i></td></tr><tr><td>1</td><td><i>SLC1A4</i></td><td>0.00004</td><td>2.695</td><td>Sensitive up vs resistant</td></tr><tr><td>2</td><td><i>NEK3</i></td... | <table><tr><td>No.</td><td>Gene ID</td></tr><tr><td>1</td><td>SLC1A4</td></tr><tr><td>2</td><td>NEK3</td></tr><tr><td>3</td><td>GLA</td></tr><tr><td>4</td><td>AKNA</td></tr><tr><td>5</td><td>ARHGAP27</td></tr><tr><td>6</td><td>LY96</td></tr><tr><td>7</td><td>DLST</td></tr><tr><td>8</td><td>MSL3</td></tr><tr><td>9</td><... | <table><tr><td>P-value</td><td>Fold difference (sensitive vs resistant)</td><td>Fold difference (description)</td></tr><tr><td>0.00004</td><td>2.695</td><td>Sensitive up vs resistant</td></tr><tr><td>0.00006</td><td>−2.544</td><td>Sensitive down vs resistant</td></tr><tr><td>0.00007</td><td>2.073</td><td>Sensitive up v... |
7f818d17e84341a2c0b2bf6e28c489b8645dd99b15ed24d66c191d01e3cc6f87.png | complex | <table><tr><td rowspan="2">Sample no.</td><td rowspan="2">Number of subjects</td><td colspan="3">RhD</td><td rowspan="2">RhCcEe</td><td rowspan="2"><i>RHD </i>zygosity*</td><td rowspan="2"><i>RHD </i>allele</td></tr><tr><td>Micro-plate</td><td>IAT</td><td>Adsorption/elute</td></tr><tr><td>13001-13030</td><td>30</td><td... | <table><tr><td rowspan="2">Sample no.</td><td rowspan="2">Number of subjects</td></tr><tr></tr><tr><td>13001-13030</td><td>30</td></tr><tr><td>13031-13033</td><td>3</td></tr><tr><td>13034-13035</td><td>2</td></tr><tr><td>13036</td><td>1</td></tr><tr><td>13037</td><td>1</td></tr><tr><td>13038</td><td>1</td></tr><tr><td>... | <table><tr><td colspan="3">RhD</td><td rowspan="2">RhCcEe</td><td rowspan="2">RHD zygosity*</td><td rowspan="2">RHD allele</td></tr><tr><td>Micro-plate</td><td>IAT</td><td>Adsorption/elute</td></tr><tr><td>–</td><td>–</td><td>+</td><td>Ccee</td><td>RHD+/RHD-</td><td>RHD1227A</td></tr><tr><td>–</td><td>–</td><td>+</td><... |
155bebd936ff645a1c8e9a6a7b894b5e4baf1886ab7d7466ce1ce6b6dfce1361.png | complex | <table><tr><td>Trial number andaverage error</td><td>User 1</td><td>User 2</td><td>User 3</td><td>User 4</td><td>User 5</td><td>User 6</td><td>User 7</td><td>User 8</td><td>User 9</td><td>User 10</td></tr><tr><td>1st trial</td><td>0.59</td><td>0.46</td><td>0.76</td><td>0.51</td><td>0.82</td><td>0.78</td><td>0.56</td><t... | <table><tr><td>Trial number andaverage error</td><td>User 1</td><td>User 2</td><td>User 3</td><td>User 4</td><td>User 5</td><td>User 6</td><td>User 7</td><td>User 8</td><td>User 9</td><td>User 10</td></tr><tr><td>1st trial</td><td>0.59</td><td>0.46</td><td>0.76</td><td>0.51</td><td>0.82</td><td>0.78</td><td>0.56</td><t... | <table><tr><td>2nd trial</td><td>0.66</td><td>0.65</td><td>0.47</td><td>0.60</td><td>0.79</td><td>0.77</td><td>0.68</td><td>0.85</td><td>0.90</td><td>0.90</td></tr><tr><td>3rd trial</td><td>0.84</td><td>0.55</td><td>0.53</td><td>0.74</td><td>0.58</td><td>0.66</td><td>0.74</td><td>0.32</td><td>0.67</td><td>0.84</td></tr... |
08d43e1041b7db57241986ad96c891ec57e9e29e00a27e96ac0e8a76f0069f01.png | complex | <table><tr><td rowspan="3">Method</td><td colspan="3">Week 4</td><td colspan="3">Week 5</td></tr><tr><td>Positive/total</td><td>Specificity (%)</td><td>Sensitivity (%)</td><td>Positive/total</td><td>Specificity (%)</td><td>Sensitivity (%)</td></tr><tr><td>FIU</td><td>18/53</td><td>72.3</td><td>83.3</td><td>12/53</td><t... | <table><tr><td>Method</td><td colspan="3">Week 4</td><td colspan="3">Week 5</td></tr></table> | <table><tr><td rowspan="2">Method</td><td>Positive/total</td><td>Specificity (%)</td><td>Sensitivity (%)</td><td>Positive/total</td><td>Specificity (%)</td><td>Sensitivity (%)</td></tr><tr><td colspan="6"></td></tr><tr><td>FIU</td><td>18/53</td><td>72.3</td><td>83.3</td><td>12/53</td><td>83.3</td><td>80</td></tr><tr><t... |
ef84145400dc2620a1486d2407a8c93bd2bae127aa99e2259f94d097d1065505.png | complex | <table><tr><td rowspan="2">Incremental # sub-types</td><td colspan="2">P-values<sup>a</sup></td></tr><tr><td>mRNA</td><td>Methylation</td></tr><tr><td>3 vs 2</td><td>0.02</td><td><0.01</td></tr><tr><td>4 vs 3</td><td>0.06</td><td>0.04</td></tr><tr><td>5 vs 4</td><td>0.41</td><td><0.01</td></tr></table> | <table><tr><td>Incremental # sub-types</td><td colspan="2">P-valuesa</td></tr></table> | <table><tr><td>Incremental # sub-types</td><td>mRNA</td><td>Methylation</td></tr><tr><td>3 vs 2</td><td>0.02</td><td><0.01</td></tr><tr><td>4 vs 3</td><td>0.06</td><td>0.04</td></tr><tr><td>5 vs 4</td><td>0.41</td><td><0.01</td></tr></table> |
caec5e7ac22c7dbce26075d293609a89edadd0084ed163b6e2029e7200c8d6c3.png | complex | <table><tr><td>Proteins</td><td colspan="4">Bonds determined by different methods</td></tr><tr><td></td><td>Known Linkages</td><td>MS2DB+</td><td>SVM</td><td>CSP</td></tr><tr><td>ST8Sia IV</td><td>142-292</td><td>142-292</td><td>142-292</td><td>142-292</td></tr><tr><td></td><td>156-356</td><td>156-356</td><td>156-356</... | <table><tr><td>Proteins</td><td colspan="4">Bonds determined by different methods</td></tr><tr><td></td><td>Known Linkages</td><td>MS2DB+</td><td>SVM</td><td>CSP</td></tr><tr><td>ST8Sia IV</td><td>142-292</td><td>142-292</td><td>142-292</td><td>142-292</td></tr><tr><td></td><td>156-356</td><td>156-356</td><td>156-356</... | <table><tr><td>Proteins</td><td colspan="4">Bonds determined by different methods</td></tr><tr><td></td><td>Known Linkages</td><td>MS2DB+</td><td>SVM</td><td>CSP</td></tr><tr><td>T VII</td><td>68-76</td><td>6</td><td>8-76</td><td>-76</td></tr><tr><td></td><td>211-214</td><td>211-214</td><td>211-214</td><td>211-214</td>... |
0301e0239387ec7217a21e3e24c94608432ccaff49d3dd5c43922dfac4431c52.png | complex | <table><tr><td rowspan="2">Variable</td><td>All NEETs Included</td><td>Economically Inactive NEETs Excluded</td></tr><tr><td>OR (95% CI)</td><td>OR (95% CI)</td></tr><tr><td colspan="3">UNIVARIATE<sup>c</sup></td></tr><tr><td colspan="3">NEET</td></tr><tr><td> No</td><td>1.00*</td><td>1.00</td></tr><tr><td> Yes</td><td... | <table><tr><td rowspan="2">Variable</td><td>All NEETs Included</td><td>Economically Inactive NEETs Excluded</td></tr><tr><td>OR (95% CI)</td><td>OR (95% CI)</td></tr><tr><td colspan="3">UNIVARIATEc</td></tr><tr><td colspan="3">NEET</td></tr><tr><td>No</td><td>1.00*</td><td>1.00</td></tr><tr><td>Yes</td><td>0.73 (0.59–0... | <table><tr><td>Intermediate</td><td>1.06 (0.78–1.45)</td><td>1.07 (0.78–1.46)</td></tr><tr><td>Routine & manual</td><td>1.40 (1.08–1.83)</td><td>1.40 (1.07–1.84)</td></tr><tr><td>Other or never worked/long-term unemployed</td><td>1.13 (0.80–1.61)</td><td>1.18 (0.82–1.70)</td></tr></table> |
2374dbcf596fae4fb0abb11637fddd00a61833dfa2321ad5261e904ace164b0c.png | simple | <table><tr><td>Group</td><td>Dose (mg/kg)</td><td>AST (IU/l)</td><td>ALT (IU/l)</td></tr><tr><td>Vehicle</td><td>–</td><td>48.65 ± 6.78**</td><td>28.59 ± 3.15**</td></tr><tr><td>Model</td><td>–</td><td>124.37 ± 10.35</td><td>75.16 ± 5.79</td></tr><tr><td>Silibinin</td><td>100</td><td>85.... | <table><tr><td>Group</td><td>Dose (mg/kg)</td><td>AST (IU/l)</td><td>ALT (IU/l)</td></tr></table> | <table><tr><td>Vehicle</td><td>–</td><td>48.65 ± 6.78**</td><td>28.59 ± 3.15**</td></tr><tr><td>Model</td><td>–</td><td>124.37 ± 10.35</td><td>75.16 ± 5.79</td></tr><tr><td>Silibinin</td><td>100</td><td>85.94 ± 5.63*</td><td>50.19 ± 4.29*</td></tr><tr><td>LAE</td><td>50</td><td>65.38 ± 4.59**</td><td>45.31 ± 6.12*</td>... |
84fbc5479299eaf4dde3ac05565fb2ca6b6c5796a759554540674b79fd519be6.png | simple | <table><tr><td>Parameters</td><td>5-year PFS</td><td>P value <sup>b</sup></td><td>5-year OS</td><td>P value <sup>b</sup></td></tr><tr><td>SUVmax <sup>a</sup></td><td></td><td>0.494</td><td></td><td>0.282</td></tr><tr><td> Low</td><td>73%</td><td></td><td>90%</td><td></td></tr><tr><td> High</td><td>57%</td><td></td><td>... | <table><tr><td>Parameters</td><td>5-year PFS</td><td>P value b</td><td>5-year OS</td><td>P value b</td></tr><tr><td>SUVmax a</td><td></td><td>0.494</td><td></td><td>0.282</td></tr><tr><td>Low</td><td>73%</td><td></td><td>90%</td><td></td></tr><tr><td>High</td><td>57%</td><td></td><td>72%</td><td></td></tr><tr><td>MTV a... | <table><tr><td>GCB</td><td>74%</td><td></td><td>88%</td><td></td></tr><tr><td>non-GCB</td><td>65%</td><td></td><td>80%</td><td></td></tr></table> |
b1e2077a0150d0b9abad901a3b490ec99ae236573cc082993c26fa6d3b9be94a.png | complex | <table><tr><td> </td><td>All (<i>N</i> = 104)</td><td>PST (<i>n</i> = 55)</td><td>WL (<i>n</i> = 49)</td><td>Statistic</td></tr><tr><td>Age in years (<i>SD</i>)</td><td>37.6 (10.8)</td><td>33.7 (10.7)</td><td>42.1 (9.2)</td><td><i>t</i>(102) = −4.81, <i>p</i> < .001</td></tr><tr><td>Female</td><td>73 (70.2)</t... | <table><tr><td></td><td>All (N = 104)</td><td>PST (n = 55)</td></tr><tr><td>Age in years (SD)</td><td>37.6 (10.8)</td><td>33.7 (10.7)</td></tr><tr><td>Female</td><td>73 (70.2)</td><td>48 (87.3)</td></tr><tr><td colspan="3">Education*</td></tr><tr><td>-lower</td><td>7 (6.7)</td><td>4 (7.3)</td></tr><tr><td>-middle</td><... | <table><tr><td>WL (n = 49)</td><td>Statistic</td></tr><tr><td>42.1 (9.2)</td><td>t(102) = −4.81, p < .001</td></tr><tr><td>25 (51.0)</td><td>χ2(1) = 16.27, p < .001</td></tr><tr><td colspan="2">Education*</td></tr><tr><td>3 (6.1)</td><td>χ2(2) = 8,62, p = .01</td></tr><tr><td>17 (34.7)</td><td></td></tr><tr><td>29 (59.... |
9025ab01c5350b8021ac714eccfcf8a2da017047f363b7d81573da52a1c88bff.png | simple | <table><tr><td>Grouping variable</td><td>Variance</td><td><i>F</i>-value</td><td><i>P</i>-value</td></tr><tr><td>Year</td><td>0.73</td><td>37.86</td><td><0.001</td></tr><tr><td>Farmland type</td><td>0.08</td><td>4.27</td><td>0.001</td></tr><tr><td>Year: Farmland type</td><td>0.13</td><td>6.48</td><td><0.001</td><... | <table><tr><td>Grouping variable</td><td>Variance</td><td>F-value</td><td>P-value</td></tr><tr><td></td><td></td><td>3</td><td><0.00</td></tr></table> | <table><tr><td>Year</td><td>0.73</td><td>7.86</td><td>1</td></tr><tr><td>Farmland type</td><td>0.08</td><td>4.27</td><td>0.001</td></tr><tr><td>Year: Farmland type</td><td>0.13</td><td>6.48</td><td><0.001</td></tr></table> |
bb1af989bf8fdc56323e33848fe66a97d1e871771edd801acb451057f6ee6fbc.png | simple | <table><tr><td>Health facility indicators</td><td>DRH</td><td>HFSUH</td><td>KGH</td><td>Over all</td></tr><tr><td>Percentage in stock of key drugs</td><td>12(80.0%)<sup>a</sup></td><td>6(40.0%)<sup>a</sup></td><td>11(73.3%)<sup>a</sup></td><td>20(66.7%)</td></tr><tr><td>% of drugs with adequate recording</td><td>11(73.... | <table><tr><td>Health facility indicators</td><td>DRH</td><td>HFSUH</td><td>KGH</td><td>Over all</td></tr></table> | <table><tr><td>Percentage in stock of key drugs</td><td>12(80.0%)a</td><td>6(40.0%)a</td><td>11(73.3%)a</td><td>20(66.7%)</td></tr><tr><td>% of drugs with adequate recording</td><td>11(73.3%) a</td><td>0a</td><td>12(80.0%)a</td><td>19(63.3)</td></tr><tr><td>Average number of stock out days during the year for adequatel... |
7b20773d2b32f5a5a68b17736d876db6b34c9a28d4dba202baa00eaa61697596.png | complex | <table><tr><td><i>Sociodemographic and clinical variables</i>a</td><td><i>Patients with TRD (</i>n=<i>12)</i></td><td><i>Comparison participants (</i>n=<i>10)</i></td><td><i>Statistic</i>b</td><td>P<i>-value</i></td></tr><tr><td>Age, years: mean (s.d.)</td><td>59.17 (8.02)</td><td>54.4 (8.37)</td><td>−1.454</td><... | <table><tr><td>Sociodemographic and clinical variablesa</td><td>Patients with TRD (n=12)</td><td>Comparison participants (n=10)</td><td>Statisticb</td><td>P-value</td></tr><tr><td>Age, years: mean (s.d.)</td><td>59.17 (8.02)</td><td>54.4 (8.37)</td><td>−1.454</td><td>0.159</td></tr></table> | <table><tr><td>Gender, male: n (%)</td><td>6 (50)</td><td>5 (50)</td><td>0</td><td>1</td></tr><tr><td>Education, years: mean (s.d.)</td><td>9.75 (5.91)</td><td>12.44 (3.39)</td><td>−1.253</td><td>0.219</td></tr><tr><td>Psychotic symptoms: n (%)</td><td>5 (41.7)</td><td></td><td></td><td></td></tr><tr><td>Comorbid anxie... |
caf079e3dfa68e55e2ed23124a467cbba64759581406d8e1209a3fc64ea2e119.png | simple | <table><tr><td>Projections</td><td>ZF-IDFT</td><td>k-<i>t</i> FOCUSS</td><td>k-<i>t</i> SLR</td><td>k-<i>t</i> RPCA</td><td>k-<i>t</i> NCRPCA</td></tr><tr><td>8</td><td>0.3281/7.3112</td><td>0.7041/16.1893</td><td>0.8328/16.9640</td><td>0.7948/17.5719</td><td>0.8268/17.8084</td></tr><tr><td>12</td><td>0.4306/8.7548</td... | <table><tr><td>Projections</td><td>ZF-IDFT</td><td>k-t FOCUSS</td><td>k-t SLR</td><td>k-t RPCA</td><td>k-t NCRPCA</td></tr><tr><td>8</td><td>0.3281/7.3112</td><td>0.7041/16.1893</td><td>0.8328/16.9640</td><td>0.7948/17.5719</td><td>0.8268/17.8084</td></tr><tr><td>12</td><td>0.4306/8.7548</td><td>0.8099/17.9173</td><td>... | <table><tr><td>Projections</td><td>ZF-IDFT</td><td>k-t FOCUSS</td><td>k-t SLR</td><td>k-t RPCA</td><td>k-t NCRPCA</td></tr><tr><td>32</td><td>0.6753/13.9492</td><td>0.9489/24.2931</td><td>0.9757/25.7613</td><td>0.9674/25.4710</td><td>0.9887/27.2034</td></tr></table> |
7ebf9e71adf18a5853e8f0bd1ad38c7133a113e43816e78ec20185f553bb3e1a.png | simple | <table><tr><td>Clinical characteristics</td><td>Total</td><td>Minimal ETE</td><td>Widely ETE</td><td><i>P</i> value*</td></tr><tr><td>Patient number</td><td>269</td><td>175 (65.1)</td><td>94 (34.9)</td><td></td></tr><tr><td>Gender (female)</td><td>204 (75.8)</td><td>144 (82.3)</td><td>60 (63.8)</td><td>0.0007</td></tr>... | <table><tr><td>Clinical characteristics</td><td>Total</td></tr><tr><td>Patient number</td><td>269</td></tr><tr><td>Gender (female)</td><td>204 (75.8)</td></tr><tr><td>Age at diagnosis (year)</td><td>46.8 ± 15.1</td></tr><tr><td>Mean tumor size (cm)</td><td>3.0 ± 1.5</td></tr><tr><td>Post-operative serum Tg level after ... | <table><tr><td>Minimal ETE</td><td>Widely ETE</td><td>P value*</td></tr><tr><td>175 (65.1)</td><td>94 (34.9)</td><td></td></tr><tr><td>144 (82.3)</td><td>60 (63.8)</td><td>0.0007</td></tr><tr><td>45.8 ± 13.7</td><td>48.6 ± 17.2</td><td>0.1506</td></tr><tr><td>2.6 ± 1.0</td><td>3.7 ± 1.9</td><td>0.0001</td></tr><tr><td>... |
4eee0b4b49c222de37612bfda0557ca0d08df3558d13786329f6457d0083af71.png | complex | <table><tr><td>Variable category</td><td>Total</td><td>EBMT</td><td>MEA</td><td><i>p</i>-value<sup>*</sup></td></tr><tr><td> </td><td>(N = 175)</td><td>(N = 59)</td><td>(N = 116)</td><td> </td></tr><tr><td>Gender</td><td>(N = 175)</td><td>(n = 59)</td><td>(n = 116)</td><td> </td></tr><tr><td>Male</td><td>(104, 59.4%)</... | <table><tr><td>Variable category</td><td>Total</td></tr><tr><td></td><td>(N = 175)</td></tr><tr><td>Gender</td><td>(N = 175)</td></tr><tr><td>Male</td><td>(104, 59.4%)</td></tr><tr><td>Female</td><td>(71, 40.6%)</td></tr><tr><td rowspan="2">Age (years) (mean ± SD)</td><td>(N = 175)</td></tr><tr><td>(56.6 ± 9.4)</td></t... | <table><tr><td>EBMT</td><td>MEA</td><td>p-value*</td></tr><tr><td>(N = 59)</td><td>(N = 116)</td><td></td></tr><tr><td>(n = 59)</td><td>(n = 116)</td><td></td></tr><tr><td>(35, 59.3%)</td><td>(69, 59.5%)</td><td>0.98</td></tr><tr><td>(24, 40.7%)</td><td>(47, 40.5%)</td><td></td></tr><tr><td>(n = 59)</td><td>(n = 116)</... |
ba069eab6d07edcc7a29925a71c3c41eff6a27f7210ffa5994e6ab1ba70e0ac1.png | simple | <table><tr><td>Design theory</td><td>Definition</td><td>Example</td></tr><tr><td>Accessible design [46]</td><td>Provides separate design features for user groups with disabilities Usually permanent and noticeableFulfills code requirements for use by individuals with disabilities </td><td>Provide the minimum level of ac... | <table><tr><td>Design theory</td></tr><tr><td>Accessible design [46]</td></tr><tr><td>Adaptable design [46]</td></tr><tr><td>Transgenerational design [48]</td></tr></table> | <table><tr><td>Definition</td><td>Example</td></tr><tr><td>Provides separate design features for user groups with disabilities Usually permanent and noticeableFulfills code requirements for use by individuals with disabilities</td><td>Provide the minimum level of accessibility required by the local building code. This ... |
ae66e30af8070c7342d2a223b1a817f16ac604245e25aeb0033b2107c126fb9a.png | complex | <table><tr><td></td><td></td><td></td><td colspan="2">dissector</td><td>sampling</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td>base</td><td>height</td><td>Grid</td><td>UGZ</td><td>BA</td><td>t</td><td></td><td></td><td></td></tr><tr><td>Structure quantified (antibody)... | <table><tr><td></td><td></td><td></td><td>dissector</td></tr><tr><td></td><td></td><td></td><td>base</td></tr><tr><td>Structure quantified (antibody)</td><td>OBJ</td><td>ssf</td><td>(μm × μm)</td></tr><tr><td>Neurofibrillar tangles (AT8)</td><td>60 ×</td><td>1/13</td><td>100 × 100</td></tr><tr><td>Microglia (Iba1)</td>... | <table><tr><td>dissector</td><td>sampling</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>height</td><td>Grid</td><td>UGZ</td><td>BA</td><td>t</td><td></td><td></td><td></td></tr><tr><td>(μm)</td><td>(μm × μm)</td><td>(μm)</td><td>(μm)</td><td>(μm)</td><td>∑OD</td><td>∑Q-</td><td>CE</td></tr><tr>... |
05122130b53d1d7d64bb1129ee2fcecd39969b01d1585ebc2deaecdde2583f46.png | complex | <table><tr><td>Group</td><td>Survivors of intimate partner violence (n =8)</td><td>Women who have not experienced violence (n = 5)</td><td>General practitioners (n = 3)</td></tr><tr><td rowspan="3">Age group</td><td>18-25: 3</td><td>18-25: 1</td><td>18-25: 0</td></tr><tr><td>26-50: 4</td><td>26-50: 4</td><td>26-50: 2</... | <table><tr><td>Group</td><td>Survivors of intimate partner violence (n =8)</td><td>Women who have not experienced violence (n = 5)</td></tr><tr><td rowspan="3">Age group</td><td>18-25: 3</td><td>18-25: 1</td></tr><tr><td>26-50: 4</td><td>26-50: 4</td></tr><tr><td>51-74: 1</td><td>51-74: 0</td></tr><tr><td>Mean age</td>... | <table><tr><td>General practitioners (n = 3)</td></tr><tr><td>18-25: 0</td></tr><tr><td>26-50: 2</td></tr><tr><td>51-74: 1</td></tr><tr><td>50.6</td></tr><tr><td>No data</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Employed 3</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Danish 3</td></tr><tr><td></td></... |
c20dc21d9a1e57cdb308e6b16af5610ca46e2e4ac0d064cb4d999260b1afefb6.png | simple | <table><tr><td>Patient Characteristic</td><td>First Line</td><td>Supporting Reference</td></tr><tr><td>Elderly</td><td>Lamotrigine or Levetiracetam</td><td>[26, 27]</td></tr><tr><td>Female of reproductive age</td><td>Lamotrigine</td><td>[25-27]</td></tr><tr><td>Pregnant</td><td>Lamotrigine</td><td>[26, 27]</td></tr><tr... | <table><tr><td>Patient Characteristic</td><td>First Line</td><td>Supporting Reference</td></tr></table> | <table><tr><td>Elderly</td><td>Lamotrigine or Levetiracetam</td><td>[26, 27]</td></tr><tr><td>Female of reproductive age</td><td>Lamotrigine</td><td>[25-27]</td></tr><tr><td>Pregnant</td><td>Lamotrigine</td><td>[26, 27]</td></tr><tr><td>Liver failure</td><td>Levetiracetam or Lamotrigine or Gabapentina</td><td>[26, 27]<... |
931360a6cb13ef5bac544a4e15df4ec5232101b85bc2b831dd154c4e20a3a0ed.png | simple | <table><tr><td>Characteristic</td><td>Number (n) or Median (Range)</td></tr><tr><td>Median age (years)</td><td>22.5 (18–26)</td></tr><tr><td>Ethnicity (n)</td><td></td></tr><tr><td>White British</td><td>8</td></tr><tr><td>Pakistani British</td><td>1</td></tr><tr><td>Indian British</td><td>2</td></tr><tr><td>Canad... | <table><tr><td>Characteristic</td><td>Number (n) or Median (Range)</td></tr><tr><td>Median age (years)</td><td>22.5 (18–26)</td></tr><tr><td>Ethnicity (n)</td><td></td></tr><tr><td>White British</td><td>8</td></tr><tr><td>Pakistani British</td><td>1</td></tr><tr><td>Indian British</td><td>2</td></tr><tr><td>Canadian (v... | <table><tr><td>Median number of lifetime sexual partners</td><td>3.5 (1–8)</td></tr><tr><td>Median number of new sexual partners (in last 12 months)</td><td>0 (0–4)</td></tr><tr><td>Previous self-test use (n)</td><td></td></tr><tr><td>Had self-tested</td><td>11</td></tr><tr><td>Had not self-tested</td><td>7</td></tr><t... |
5ac5d5e3d676ed868c9dacba2d132fe883a3f2097c2ae5c638525de4635c8bde.png | simple | <table><tr><td>Data set</td><td>P systems</td><td>GA</td><td>PSO</td><td>ACO</td><td><i>k</i>-means</td></tr><tr><td><i>AD_5_2 </i></td><td>326.44 ± 0.0105</td><td>332.31 ± 0.4792</td><td>326.44 ± 0.0128</td><td>326.45 ± 0.0344</td><td>332.47 ± 3.1286</td></tr><tr><td><i>Data_9_2 </i></td><td>5... | <table><tr><td>Data set</td><td>P systems</td><td>GA</td><td>PSO</td><td>ACO</td><td>k-means</td></tr><tr><td>AD_5_2</td><td>326.44 ± 0.0105</td><td>332.31 ± 0.4792</td><td>326.44 ± 0.0128</td><td>326.45 ± 0.0344</td><td>332.47 ± 3.1286</td></tr><tr><td>Da</td><td></td><td>593.7</td><td></td><td>591.42 </td><td></td></... | <table><tr><td>Data set</td><td>P systems</td><td>GA</td><td>PSO</td><td>ACO</td><td>k-means</td></tr><tr><td>ta_9_2</td><td>591.06 ± 0.0280</td><td>2 ± 0.2635</td><td>591.14 ± 0.0303</td><td>± 0.0372</td><td>623.57 ± 3.1326</td></tr><tr><td>Square_4</td><td>2379.74 ± 0.0189</td><td>2380.33 ± 0.6319</td><td>2379.74 ± 0... |
a24fed89aaae59939d81de1c6a1162f57375aa33bca946ea23ca04afedd2bc4b.png | complex | <table><tr><td>Characteristic</td><td>Focus groups (<i>N</i> = 5)</td><td>Interviews (<i>N</i> = 10)</td></tr><tr><td>No. participants</td><td><i>n</i> = 20</td><td><i>n</i> = 10</td></tr><tr><td>Mean age (years)</td><td>88.4 (SD ± 5.20)</td><td>88.9 (SD ± 3.60)</td></tr><tr><td colspan="3">Gender</td></tr><t... | <table><tr><td>Characteristic</td><td>Focus groups (N = 5)</td><td>Interviews (N = 10)</td></tr><tr><td>No. participants</td><td>n = 20</td><td>n = 10</td></tr><tr><td>Mean age (years)</td><td>88.4 (SD ± 5.20)</td><td>88.9 (SD ± 3.60)</td></tr><tr><td colspan="3">Gender</td></tr><tr><td>Male</td><td>20 % (n = 4)</td><t... | <table><tr><td>University (Bachelors)</td><td>5 % (n = 1)</td><td>10 % (n = 1)</td></tr><tr><td>University (Masters)</td><td>5 % (n = 1)</td><td>-</td></tr><tr><td>University (PhD/MD)</td><td>-</td><td>-</td></tr><tr><td>Other education</td><td>5 % (n = 1)</td><td>20 % (n = 2)</td></tr><tr><td colspan="3">Perceived Hea... |
dbbc8d224014da2b223a49590986a9221f1ac3a3220356c066768488c978afb4.png | complex | <table><tr><td rowspan="2">Age (yr)</td><td colspan="2">Gender</td><td rowspan="2">Total</td></tr><tr><td>Male</td><td>Female</td></tr><tr><td>12</td><td>146 (51.6)</td><td>137 (48.4)</td><td>283 (34.9)</td></tr><tr><td>13</td><td>121 (62.7)</td><td>72 (37.3)</td><td>193 (23.8)</td></tr><tr><td>14</td><td>105 (61.8)</t... | <table><tr><td rowspan="2">Age (yr)</td><td colspan="2">Gender</td><td rowspan="2">Total</td></tr><tr><td>Male</td><td>Female</td></tr><tr><td>12</td><td>146 (51.6)</td><td>137 (48.4)</td><td>283 (34.9)</td></tr><tr><td>13</td><td>121 (62.7)</td><td>72 (37.3)</td><td>193 (23.8)</td></tr></table> | <table><tr><td>14</td><td>105 (61.8)</td><td>65 (38.2)</td><td>170 (21.0)</td></tr><tr><td>15</td><td>87 (53.0)</td><td>77 (47.0)</td><td>164 (20.2)</td></tr><tr><td>Total</td><td>459 (56.7)</td><td>351 (43.3)</td><td>810 (100)</td></tr></table> |
6d9c502b8cd438110f427689f322ef40ef6f13f30cc7e889c1306a55530ceef4.png | complex | <table><tr><td>Variable</td><td>Cases(<i>n</i> = 175)</td><td>Controls(<i>n</i> = 175)</td></tr><tr><td>Mean age ± SD</td><td>58.15 ± 20.56</td><td>57.76 ± 20.09</td></tr><tr><td colspan="3">Classification score of disease conditions</td></tr><tr><td> 1</td><td>40(22.9%)</td><td>40(22.9%)</td></tr><tr><t... | <table><tr><td>Variable</td></tr><tr><td>Mean age ± SD</td></tr><tr><td>Classification score of disease conditions</td></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>4</td></tr><tr><td>5</td></tr><tr><td>Gender</td></tr><tr><td>Male</td></tr><tr><td>Female</td></tr><tr><td>Community infections</t... | <table><tr><td>Cases(n = 175)</td><td>Controls(n = 175)</td></tr><tr><td>58.15 ± 20.56</td><td>57.76 ± 20.09</td></tr><tr><td colspan="2">Classification score of disease conditions</td></tr><tr><td>40(22.9%)</td><td>40(22.9%)</td></tr><tr><td>63(36.0%)</td><td>63(36.0%)</td></tr><tr><td>42(24.0%)</td><td>42(24.0%)</td>... |
e0d3d0093a9f519c1e70772bf080ed9a97d2928c6987fad75b59984ebf019955.png | complex | <table><tr><td>Element type of membrane</td><td colspan="2">Pressure driving force bar</td></tr><tr><td>NF90-4040</td><td colspan="2">6.96 bar</td></tr><tr><td>Parameters mg/L</td><td>Internal (Feed water) mg/L</td><td>Output Permeable (NF Process) mg/L</td></tr><tr><td>TDS</td><td>3902.78</td><td>212.58</td></tr><tr><... | <table><tr><td>Element type of membrane</td><td colspan="2">Pressure driving force bar</td></tr><tr><td>NF90-4040</td><td colspan="2">6.96 bar</td></tr><tr><td>Parameters mg/L</td><td>Internal (Feed water) mg/L</td><td>Output Permeable (NF Process) mg/L</td></tr></table> | <table><tr><td>TDS</td><td>3902.78</td><td>212.58</td></tr><tr><td>Cl ̄1</td><td>1223.4</td><td>101.31</td></tr><tr><td>Na+1</td><td>812.41</td><td>67.53</td></tr></table> |
b0f93238708b830775c17a071458a15e65cc24abd57a23920d7d63c032ed158b.png | complex | <table><tr><td> </td><td colspan="5">Dependent variables</td></tr><tr><td> </td><td>HH CI</td><td>HH ACI</td><td>HH SCI</td><td>HH SACI</td><td>N</td></tr><tr><td>Public expenditure on health care (% of GDP)</td><td>0.0036*</td><td>0.0108**</td><td>0.0004</td><td>0.0035</td><td>22</td></tr><tr><td>Gini index</td><td>&#... | <table><tr><td></td><td colspan="5">Dependent variables</td></tr><tr><td></td><td>HH CI</td><td>HH ACI</td><td>HH SCI</td><td>HH SACI</td><td>N</td></tr><tr><td>Public expenditure on health care (% of GDP)</td><td>0.0036*</td><td>0.0108**</td><td>0.0004</td><td>0.0035</td><td>22</td></tr><tr><td>Gini index</td><td>−0.0... | <table><tr><td></td><td colspan="5">s</td></tr><tr><td></td><td>CI</td><td>ACI</td><td>SCI</td><td>SACI</td><td>N</td></tr><tr><td>Public expenditure on health care (% of GDP)</td><td>−0.0012</td><td>0.0032</td><td>−0.0017</td><td>0.0001</td><td>22</td></tr><tr><td>Gini index</td><td>0.0015**</td><td>0.0020</td><td>0.0... |
710fc963f1611a8ba5a47eef10213aafbef6031babf566a50803d000cf779bb8.png | complex | <table><tr><td>Gene symbol</td><td>Description</td><td>Gene function</td><td>Gene expression in IBS</td><td>Psychiatric diseases</td><td>Reference</td></tr><tr><td>NGF</td><td>Nerve growth factor</td><td>Pro-inflammatory mediator; psychoneuroendocrine modulator</td><td>Overexpression (in rat model)</td><td>Anxiety, chr... | <table><tr><td>Gene symbol</td><td>Description</td><td>Gene function</td><td>Gene expression in IBS</td><td>Psychiatric diseases</td><td>Reference</td></tr><tr><td>NGF</td><td>Nerve growth factor</td><td>Pro-inflammatory mediator; psychoneuroendocrine modulator</td><td>Overexpression (in rat model)</td><td>Anxiety, chr... | <table><tr><td>Gene symbol</td><td>Description</td><td>Gene function</td><td>Gene expression in IBS</td><td>Psychiatric diseases</td><td>Reference</td></tr><tr><td>5-HTTLPR</td><td>5-hydroxytryptamine transporter gene-linked polymorphic region</td><td>Serotonin transporter</td><td>SNP</td><td>Depression, anxiety, recta... |
92aac1a2949dd65dd82b46bb60385cdfd7f5adc6749e5678054cb78464b3986b.png | simple | <table><tr><td>Recombinant strain</td><td>Transfer medium</td><td>Resistant colonies (%)</td></tr><tr><td>RQ7/pDH10</td><td>SVO</td><td>104.92 ± 9.57</td></tr><tr><td></td><td>SVO + Kan</td><td>106.66 ± 3.56</td></tr><tr><td>Tm/pDH10</td><td>SVO</td><td>100.96 ± 23.72</td></tr><tr><td></td><td>SVO + Kan<... | <table><tr><td>Recombinant strain</td><td>Transfer medium</td><td>Resistant colonies (%)</td></tr><tr><td>RQ7/pDH10</td><td>SVO</td><td>104.92 ± 9.57</td></tr><tr><td></td><td>SVO + Kan</td><td>106.66 ± 3.56</td></tr></table> | <table><tr><td>Recombinant strain</td><td>Transfer medium</td><td>Resistant colonies (%)</td></tr><tr><td>Tm/pDH10</td><td>SVO</td><td>100.96 ± 23.72</td></tr><tr><td></td><td>SVO + Kan</td><td>108.59 ± 7.54</td></tr></table> |
08edef8e04241d19e01e94827391630fab6049b1871720f59f4abfdee8b7c883.png | simple | <table><tr><td> </td><td>Improvement (<i>N</i> = 57)Mean ± SD/<i>n</i> (%)</td><td>Nonimprovement (<i>N</i> = 52)Mean ± SD/<i>n</i> (%)</td><td><i>t</i>/<i>χ</i><sup>2</sup></td><td><i>P</i> value</td></tr><tr><td>Age (years)</td><td>47.14 ± 11.79</td><td>47.82 ± 11.11</td><td>−0.30</td><... | <table><tr><td></td><td>Improvement (N = 57)Mean ± SD/n (%)</td><td>Nonimprovement (N = 52)Mean ± SD/n (%)</td><td>t/χ2</td><td>P value</td></tr><tr><td>Age (years)</td><td>47.14 ± 11.79</td><td>47.82 ± 11.11</td><td>−0.30</td><td>0.763</td></tr><tr><td>Gender</td><td></td><td></td><td>0.22</td><td>0.637</td></tr><tr><... | <table><tr><td>Lower than high school</td><td>27 (64.29)</td><td>44 (65.67)</td></tr><tr><td>High school and above</td><td>15 (35.71)</td><td>23 (34.33)</td></tr></table> |
d7a61b9a5cf1e5d4a5f6eba7bf8d8a0ac852459e15041554177113c964c71cf6.png | simple | <table><tr><td>Nucleotide (genomic)</td><td>Nucleotide (cDNA)</td><td>Amino Acid</td><td>Type</td><td>Age at Onset</td><td>Number of affected</td><td>TCGA_ID</td><td>Previous Reported</td></tr><tr><td>11:108098418C>T</td><td>c.G67T</td><td>p.R23X</td><td>Nonsense</td><td>71</td><td>1</td><td>TCGA-RD-A8MV*</td><td>NA... | <table><tr><td>Nucleotide (genomic)</td><td>Nucleotide (cDNA)</td><td>Amino Acid</td><td>Type</td><td>Age at Onset</td><td>Number of affected</td><td>TCGA_ID</td><td>Previous Reported</td></tr><tr><td>11:108098418C>T</td><td>c.G67T</td><td>p.R23X</td><td>Nonsense</td><td>71</td><td>1</td><td>TCGA-RD-A8MV*</td><td>NA</t... | <table><tr><td>Nucleotide (genomic)</td><td>Nucleotide (cDNA)</td><td>Amino Acid</td><td>Type</td><td>Age at Onset</td><td>Number of affected</td><td>TCGA_ID</td><td>Previous Reported</td></tr><tr><td>11:108183151G>T</td><td>c.G5932T</td><td>p.E1978X</td><td>Nonsense</td><td>41,64</td><td>2</td><td>TCGA-BR-6710TCGA-BR-... |
f0d6dea8b4ee995f2823e95db2a445636a71659f3f63cb1e217d244789b2b812.png | simple | <table><tr><td>Sector</td><td><i>N</i></td><td>pH</td><td>Tot C%</td><td>Tot N%</td><td>P (Al) mg/100 g</td><td>P (HCl) mg/100 g</td><td>K (Al) mg/100 g</td><td>K (HCl) mg/100 g</td><td>Mg (Al) mg/100 g</td><td>K (Al)/Mg (Al)</td><td>Ca (Al) mg/100 g</td><td>Cu (HCl) mg/1000 g</td></tr><tr><td>A1</td><td>6</td><td>5.9 ... | <table><tr><td>Sector</td><td>N</td><td>pH</td><td>Tot C%</td><td>Tot N%</td><td>P (Al) mg/100 g</td><td>P (HCl) mg/100 g</td><td>K (Al) mg/100 g</td><td>K (HCl) mg/100 g</td><td>Mg (Al) mg/100 g</td><td>K (Al)/Mg (Al)</td><td>Ca (Al) mg/100 g</td><td>Cu (HCl) mg/1000 g</td></tr><tr><td>A1</td><td>6</td><td>5.9 ± 0.1 c... | <table><tr><td>Sector</td><td>N</td><td>pH</td><td>Tot C%</td><td>Tot N%</td><td>P (Al) mg/100 g</td><td>P (HCl) mg/100 g</td><td>K (Al) mg/100 g</td><td>K (HCl) mg/100 g</td><td>Mg (Al) mg/100 g</td><td>K (Al)/Mg (Al)</td><td>Ca (Al) mg/100 g</td><td>Cu (HCl) mg/1000 g</td></tr><tr><td>Total</td><td>48</td><td>6.0 ± 0... |
f57ff703d8e8bd612bf4d18a2f7b256536764766724010471615534800285f35.png | complex | <table><tr><td rowspan="2">Component</td><td colspan="2">Low-N Plot</td><td rowspan="2">Net Change (g N m<sup>–2</sup>)</td><td colspan="2">High-N Plot</td><td rowspan="2">Net Change (g N m<sup>−2</sup>)</td></tr><tr><td>Before</td><td>After</td><td>Before</td><td>After</td></tr><tr><td colspan="7">N input&... | <table><tr><td rowspan="2">Component</td><td colspan="2">Low-N Plot</td><td rowspan="2">Net Change (g N m–2)</td><td>High-N Plot</td></tr><tr><td>Before</td><td>After</td><td>Before</td></tr><tr><td colspan="5">N input–output (g N m−2 year−1)</td></tr><tr><td>N input</td><td>0</td><td>5</td><td>5</td><td>0</td></tr><tr... | <table><tr><td>High-N Plot</td><td rowspan="2">Net Change (g N m−2)</td></tr><tr><td>After</td></tr><tr><td colspan="2">N input–output (g N m−2 year−1)</td></tr><tr><td>15</td><td>15</td></tr><tr><td>2.67</td><td>2.25</td></tr><tr><td></td><td>12.75</td></tr><tr><td colspan="2">N storage (g N m−2)</td></tr><tr><td>19.1... |
cf928112e2442427e1e804071d514e565240fb767e56d40ae0831dd0abd5ca58.png | complex | <table><tr><td> </td><td> </td><td colspan="5">Categories at 6 (±1) months</td><td> </td><td> </td><td> </td></tr><tr><td>Baseline category</td><td>Num. of patients<sup>1</sup></td><td>A</td><td>B</td><td>C</td><td>D</td><td>E</td><td>Missing at 6 months<sup>2</sup></td><td>Category improved<sup>2</sup></td><td>Ca... | <table><tr><td></td><td></td><td colspan="5">Categories at 6 (±1) months</td><td></td><td></td><td></td></tr><tr><td>Baseline category</td><td>Num. of patients1</td><td>A</td><td>B</td><td>C</td><td>D</td><td>E</td><td>Missing at 6 months2</td><td>Category improved2</td><td>Category worsened2</td></tr><tr><td>A</td><td... | <table><tr><td>Missing</td><td>3 (0.3%)</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>3</td><td></td><td></td></tr><tr><td>Total</td><td>1182 (100%)</td><td>230 (19%)</td><td>284 (24%)</td><td>70 (6%)</td><td>66 (6%)</td><td>9 (1%)</td><td>523 (44%)</td><td>239 (24%)</td><td>48 (6%)</td></tr></table> |
b9e1119d2d4b07a4f499ac44794dc005c8edf95b1ce59a8d4565258b8afc5d4a.png | complex | <table><tr><td colspan="3"></td><td colspan="3">Delayed Effect</td><td colspan="3">Genetic Effect</td></tr><tr><td colspan="3">Traumatic reaction (ref: 17–49 on PCL-S)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td colspan="2">FY2011</td><td>OR</td><td colspan="2">95% CI</td><td>O... | <table><tr><td colspan="3"></td><td colspan="3">Delayed Effect</td><td colspan="3">Genetic Effect</td></tr><tr><td colspan="3">Traumatic reaction (ref: 17–49 on PCL-S)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td colspan="2">FY2011</td><td>OR</td><td colspan="2">95% CI</td><td>OR</td>... | <table><tr><td colspan="3"></td><td colspan="3">Delayed Effect</td><td colspan="3">Genetic Effect</td></tr><tr><td></td><td></td><td>Women</td><td>1.27</td><td>1.18</td><td>1.36</td><td>1.30</td><td>1.22</td><td>1.40</td></tr><tr><td></td><td colspan="2">Age (Ref: 50–64)</td><td></td><td></td><td></td><td></td><td></td... |
025f39379bfe51bc40ccfd4016fd0121a077e2a25a2a8020a5d6ca68ec48b23d.png | simple | <table><tr><td></td><td>M5:M5</td><td>M5:G1F</td><td>M5:M3G1F</td><td>M5:G0F</td><td>M5:M3G0F</td><td>G0F:G0F</td></tr><tr><td>Calculated relative</td><td>0.62%</td><td>1.12%</td><td>0.11%</td><td>5.29%</td><td>0.18%</td><td>45.43%</td></tr><tr><td>Calculated relative to the most abundant G0F:G0F</td><td>1.36%</td><td>... | <table><tr><td></td><td>M5:M5</td><td>M5:G1F</td><td>M5:M3G1F</td><td>M5:G0F</td><td>M5:M3G0F</td><td>G0F:G0F</td></tr></table> | <table><tr><td>Calculated relative</td><td>0.62%</td><td>1.12%</td><td>0.11%</td><td>5.29%</td><td>0.18%</td><td>45.43%</td></tr><tr><td>Calculated relative to the most abundant G0F:G0F</td><td>1.36%</td><td>2.46%</td><td>0.24%</td><td>11.64%</td><td>0.40%</td><td>100%</td></tr><tr><td>Observed relative to the most abu... |
1c39ab3c6f05c1c2fcc97b4f711243f0a7cd45cf4b8772adf3c680abb725d3f8.png | simple | <table><tr><td>Variable</td><td>Normal BMD group (N = 17)</td><td>Low BMD group (N = 17)</td><td>MannWhitney p-value</td></tr><tr><td>Trunk</td><td> </td><td> </td><td> </td></tr><tr><td>Tilt ROM</td><td>4.05 ± 1.31</td><td>4.34 ± 1.79</td><td>0.53</td></tr><tr><td>Rotation ROM</td><td>16.06 ± 4.46</td><... | <table><tr><td>Variable</td><td>Normal BMD group (N = 17)</td></tr><tr><td>Trunk</td><td></td></tr><tr><td>Tilt ROM</td><td>4.05 ± 1.31</td></tr><tr><td>Rotation ROM</td><td>16.06 ± 4.46</td></tr><tr><td>Obliquity ROM</td><td>9.49 ± 2.59</td></tr><tr><td>Hip</td><td></td></tr><tr><td>Sagittal ROM</td><td>41.24 ± 7.36</... | <table><tr><td>Low BMD group (N = 17)</td><td>MannWhitney p-value</td></tr><tr><td></td><td></td></tr><tr><td>4.34 ± 1.79</td><td>0.53</td></tr><tr><td>12.60 ± 4.96</td><td>0.02*</td></tr><tr><td>8.52 ± 3.03</td><td>0.32</td></tr><tr><td></td><td></td></tr><tr><td>38.39 ± 5.57</td><td>0.17</td></tr><tr><td>11.42 ± 3.17... |
ef905c51f5da0560a779c0d5fc3fbfb140c4e715380a1811d4bf377535002991.png | complex | <table><tr><td colspan="2"> </td></tr><tr><td colspan="2">Socio-demographic characteristics</td></tr><tr><td>Mean age (range) years</td><td>21 (17 – 30)</td></tr><tr><td>Occupation (n)</td><td> </td></tr><tr><td> Farmer</td><td>3</td></tr><tr><td> Factory worker</td><td>2</td></tr><tr><td> Student</td><td>1</td><... | <table><tr><td colspan="2"></td></tr><tr><td colspan="2">Socio-demographic characteristics</td></tr><tr><td>Mean age (range) years</td><td>21 (17 – 30)</td></tr><tr><td>Occupation (n)</td><td></td></tr><tr><td>Farmer</td><td>3</td></tr><tr><td>Factory worker</td><td>2</td></tr><tr><td>Student</td><td>1</td></tr><tr><td... | <table><tr><td colspan="2"></td></tr><tr><td>Married</td><td>6</td></tr><tr><td>Perception of economic status (n)</td><td></td></tr><tr><td>Similar to other households in this area</td><td>6</td></tr><tr><td>Parity (n)</td><td></td></tr><tr><td>Nulliparous</td><td>4</td></tr><tr><td>Multiparous</td><td>2</td></tr><tr><... |
a8e86ede7668cbeadc6bcedca4e7690d90475d179d2424f61d4b447ad7c6bf28.png | complex | <table><tr><td colspan="2"><i>Sociodemographic characteristics</i></td><td colspan="2"><i>Health-related characteristics</i></td></tr><tr><td>Males N (%)</td><td>119 (41.8)</td><td>Smokers N (%)</td><td>81 (28.4)</td></tr><tr><td>Mean Age in years (SD)</td><td>50.18 (10.1)</td><td>Mean Pack-years for smokers (SD)</td><... | <table><tr><td colspan="2">Sociodemographic characteristics</td><td colspan="2">Health-related characteristics</td></tr><tr><td>Males N (%)</td><td>119 (41.8)</td><td>Smokers N (%)</td><td>81 (28.4)</td></tr><tr><td>Mean Age in years (SD)</td><td>50.18 (10.1)</td><td>Mean Pack-years for smokers (SD)</td><td>24.82 (21.8... | <table><tr><td colspan="2"></td><td>Mean Health Assessment (in a scale from 1 to 10) (SD)</td><td>7.48 (1.4)</td></tr></table> |
cbe0db9442becf2bce3556789bf849207df97183f9cc3a937181013210669d99.png | simple | <table><tr><td> </td><td>Prevalence %</td><td>Step 1: Multivariable <i>β </i>(95% CI) Adjusted for age, sex and BMI<sup>f</sup></td><td>Step 2: Multivariable <i>β </i>(95% CI)<sup>§ </sup>Further adjusted for all variables significant in Step 1</td></tr><tr><td>Diagnosed OA of:</td><td> </td><td> </td><t... | <table><tr><td></td><td>Prevalence %</td><td>Step 1: Multivariable β (95% CI) Adjusted for age, sex and BMIf</td><td>Step 2: Multivariable β (95% CI)§ Further adjusted for all variables significant in Step 1</td></tr><tr><td>Diagnosed OA of:</td><td></td><td></td><td></td></tr><tr><td>Neck</td><td>168 (15)</td><td>2.72... | <table><tr><td></td><td>Prevalence %</td><td>Step 1: Multivariable β (95% CI) Adjusted for age, sex and BMIf</td><td>Step 2: Multivariable β (95% CI)§ Further adjusted for all variables significant in Step 1</td></tr><tr><td>Pain in the:</td><td></td><td></td><td></td></tr><tr><td>Neck (yes/no)</td><td>514 (47)</td><td... |
580d3e21cfa11f33757f940dde7efb238ceacb7a6b4ff969a933cad9cde2953c.png | complex | <table><tr><td></td><td></td><td colspan="2">GGT</td><td colspan="2">Vitamin C</td></tr><tr><td></td><td>Sample (<i>n</i>)</td><td>β-Coefficient</td><td><i>p</i>-Value for trend</td><td>β-Coefficient</td><td><i>p</i>-Value for trend</td></tr><tr><td>Race</td></tr><tr><td> Non-Hispanic white</td><td>4,485</td>... | <table><tr><td></td><td></td><td colspan="2">GGT</td><td colspan="2">Vitamin C</td></tr><tr><td></td><td>Sample (n)</td><td>β-Coefficient</td><td>p-Value for trend</td><td>β-Coefficient</td><td>p-Value for trend</td></tr><tr><td>Race</td><td colspan="5"></td></tr><tr><td>Non-Hispanic white</td><td>4,485</td><td>0.073</... | <table><tr><td></td><td></td><td colspan="2">GGT</td><td colspan="2">Vitamin C</td></tr><tr><td></td><td>Sample (n)</td><td>β-Coefficient</td><td>p-Value for trend</td><td>β-Coefficient</td><td>p-Value for trend</td></tr><tr><td>25–29.9</td><td>3,567</td><td>0.045</td><td>< 0.01</td><td>−0.090</td><td>< 0.01</td></tr><... |
1673cd4f4944e6891fe2ea91b89f06d878f22d5a4fbda1f73d67429e81d772f2.png | complex | <table><tr><td></td><td colspan="2">Men (N = 1206)</td><td colspan="2">Women (N = 1681)</td></tr><tr><td>Numbers of deformities</td><td>% (N)</td><td>95% CI (%)</td><td>% (N)</td><td>95% CI (%)</td></tr><tr><td>At least 1 deformity</td><td>9.7 (117)</td><td>8.0, 11.</td><td>7.8 (131)</td><td>46.5, 9.1</td></tr><tr><td>... | <table><tr><td></td><td colspan="2">Men (N = 1206)</td><td colspan="2">Women (N = 1681)</td></tr><tr><td>Numbers of deformities</td><td>% (N)</td><td>95% CI (%)</td><td>% (N)</td><td>95% CI (%)</td></tr><tr><td>At least </td><td>9.7 (</td><td>8.0, </td><td>7.8 (13</td><td>46.</td></tr></table> | <table><tr><td>1 deformity</td><td>117)</td><td>11.</td><td>1)</td><td>5, 9.1</td></tr><tr><td>2 deformities</td><td>3.0 (36)</td><td>2.0, 4.0</td><td>2.5 (42)</td><td>1.8, 3.2</td></tr><tr><td>3 deformities or more</td><td>1.0 (13)</td><td>0.4, 1.6</td><td>1.4 (26)</td><td>0.8, 2.0</td></tr><tr><td>All</td><td>13.8 (1... |
6aaa32c92ca6fce8e7cb83d9f7d598b65bbbca8daf888ea1c614e31162ced081.png | complex | <table><tr><td>Types</td><td><i>n</i></td><td colspan="3">Age (yr) (%)</td><td colspan="2">Menstrual status (%)</td></tr><tr><td> </td><td> </td><td>≤ 40</td><td>41 to 60</td><td>>60</td><td>Postmenopausal</td><td>Premenopausal</td></tr><tr><td>Type I</td><td>55</td><td>12 (21.8)</td><td>39 (70.9)</td><td>4 (7... | <table><tr><td>Types</td><td>n</td><td colspan="2">Age (yr) (%)</td></tr><tr><td></td><td></td><td>≤ 40</td><td>41 to 60</td></tr><tr><td>Type I</td><td>55</td><td>12 (21.8)</td><td>39 (70.9)</td></tr><tr><td>Type II</td><td>30</td><td>4 (13.3)</td><td>24 (80.0)</td></tr><tr><td>Type III</td><td>5</td><td>1 (20.0)</td>... | <table><tr><td>Age (yr) (%)</td><td colspan="2">Menstrual status (%)</td></tr><tr><td>>60</td><td>Postmenopausal</td><td>Premenopausal</td></tr><tr><td>4 (7.3)</td><td>22 (20.0)</td><td>33 (80.0)</td></tr><tr><td>2 (6.7)</td><td>17 (56.7)</td><td>13 (43.3)</td></tr><tr><td>1 (20.0)</td><td>1 (20.0)</td><td>4 (80.0)</td... |
b63fc1ec2b728339ac3b5d4bcde195f143916d425a1ea8080c2b09bca1ee9a71.png | simple | <table><tr><td>marker</td><td># of markers</td><td>detectable strains</td><td>data quality</td></tr><tr><td>Minimal set of SNPs</td><td>2</td><td>known</td><td>perfect</td></tr><tr><td>All SNPs + VNTRs</td><td>150+15</td><td>some unknown</td><td>moderate</td></tr><tr><td>CDSs</td><td>~10,000</td><td>many unknown</td><t... | <table><tr><td>marker</td><td># of markers</td></tr><tr><td>Minimal set of SNPs</td><td>2</td></tr><tr><td>All SNPs + VNTRs</td><td>150+15</td></tr><tr><td>CDSs</td><td>~10,000</td></tr><tr><td>Sequence alignment</td><td>~5,300,000</td></tr></table> | <table><tr><td>detectable strains</td><td>data quality</td></tr><tr><td>known</td><td>perfect</td></tr><tr><td>some unknown</td><td>moderate</td></tr><tr><td>many unknown</td><td>poor</td></tr><tr><td>arbitrary</td><td>arbitrary</td></tr></table> |
077a079636ae9c8b288c44452837829e766ab5708883e3deaf8a67a0c27a5461.png | complex | <table><tr><td rowspan="2">Factor</td><td colspan="2">Patients no</td><td rowspan="2">P Value</td></tr><tr><td>CR</td><td>PR</td></tr><tr><td>Sex</td><td></td><td></td><td rowspan="3">0.889</td></tr><tr><td>Male</td><td>45 (64.2%)</td><td>7 (10.2%)</td></tr><tr><td>Female</td><td>15 (21.4%)</td><td>3 (4.2%)</td></tr><t... | <table><tr><td rowspan="2">Factor</td><td colspan="2">Patients no</td><td rowspan="2">P Value</td></tr><tr><td>CR</td><td>PR</td></tr><tr><td>Sex</td><td></td><td></td><td rowspan="3">0.889</td></tr><tr><td>Male</td><td>45 (64.2%)</td><td>7 (10.2%)</td></tr><tr><td>Female</td><td>15 (21.4%)</td><td>3 (4.2%)</td></tr><t... | <table><tr><td>Baseline T stage</td><td></td><td></td><td rowspan="5"><0 .001</td></tr><tr><td>T1</td><td>7 (10.1%)</td><td></td></tr><tr><td>T2</td><td>26 (37.1%)</td><td></td></tr><tr><td>T3</td><td>25 (35.7%)</td><td>4 (5.7%)</td></tr><tr><td>T4</td><td>3 (4.3%)</td><td>5 (7.1%)</td></tr><tr><td>Baseline N stage</td... |
dfab385948ff569c784f1a7fe43819ab4da57afd55617957da5ecaff1571ccc7.png | complex | <table><tr><td></td><td></td><td colspan="6">ELISA</td><td colspan="4">PCR</td></tr><tr><td></td><td></td><td colspan="2"><i>B. bigemina</i></td><td colspan="2"><i>B. bovis</i></td><td colspan="2"><i>B. bigemina and B. bovis</i></td><td colspan="2"><i>B. bigemina</i></td><td colspan="2"><i>B. bovis</i></td></tr><tr><td... | <table><tr><td></td><td></td><td colspan="6">ELISA</td><td colspan="3">PCR</td></tr><tr><td></td><td></td><td colspan="2">B. bigemina</td><td colspan="2">B. bovis</td><td colspan="2">B. bigemina and B. bovis</td><td colspan="2">B. bigemina</td><td>B. bovis</td></tr><tr><td>Governorate</td><td>No. tested animals</td><td... | <table><tr><td>PCR</td></tr><tr><td>B. bovis</td></tr><tr><td>Infection (%)</td></tr><tr><td>28.6</td></tr><tr><td>1.4</td></tr><tr><td>3.7</td></tr></table> |
60a1f67059df53b73f2c6aaa5e8406037f4e554a843b212b6b8666101fae1564.png | simple | <table><tr><td>Author</td><td>Aims scope</td><td>Ethical dimension</td><td>Study design</td><td>Rigour</td><td>Analysis procedure</td><td>Depth/detail</td><td>Credibility</td><td>Relevance transferability</td><td>Contribution to knowledge</td><td>Overall quality</td></tr><tr><td>Andersen et al. (a) and (b)</td><td>VG</... | <table><tr><td>Author</td><td>Aims scope</td><td>Ethical dimension</td><td>Study design</td><td>Rigour</td><td>Analysis procedure</td><td>Depth/detail</td><td>Credibility</td><td>Relevance transferability</td><td>Contribution to knowledge</td><td>Overall quality</td></tr><tr><td>Andersen et al. (a) and (b)</td><td>VG</... | <table><tr><td>Author</td><td>Aims scope</td><td>Ethical dimension</td><td>Study design</td><td>Rigour</td><td>Analysis procedure</td><td>Depth/detail</td><td>Credibility</td><td>Relevance transferability</td><td>Contribution to knowledge</td><td>Overall quality</td></tr><tr><td>t al.</td><td>G</td><td>G</td><td></td><... |
f4648de2f8e4eec2d881e6e34f0b5a8ccc04246803f5315d7a2553f18c29bcec.png | complex | <table><tr><td rowspan="2">Sample</td><td colspan="4">Peel</td><td colspan="4">Pulp</td></tr><tr><td><i>K. pneumoniae</i></td><td>Activity</td><td><i>S. aureus</i></td><td>Activity</td><td><i>K. pneumoniae</i></td><td>Activity</td><td><i>S. aureus</i></td><td>Activity</td></tr><tr><td>Jeruk Nipis</td><td>4.2 ± 1.8... | <table><tr><td rowspan="2">Sample</td><td colspan="4">Peel</td><td colspan="4">Pulp</td></tr><tr><td>K. pneumoniae</td><td>Activity</td><td>S. aureus</td><td>Activity</td><td>K. pneumoniae</td><td>Activity</td><td>S. aureus</td><td>Activity</td></tr><tr><td>Jeruk N</td><td></td><td>Bacte</td><td>3.5 ±1.</td><td></td><t... | <table><tr><td>ipis</td><td>4.2 ± 1.8a</td><td>ricide</td><td>4a,b</td><td>Bacteriostatic</td><td>.4a,b</td><td>de</td><td>a,b</td><td>tericide</td></tr><tr><td>Jeruk Purut</td><td>4.6 ± 1.2a</td><td>Bacteriostatic</td><td>4.8 ± 1.7a,b</td><td>Bactericide</td><td>5.5 ± 1.1a,b</td><td>Bactericide</td><td>3.4 ± 0.9a,b</t... |
f42847331f4f26cf8b67f272606da2f57712659e10eb7406f7f049b887b72836.png | simple | <table><tr><td>Gene symbol</td><td>Gene title</td><td>log2 fold change</td><td><i>P</i>-value</td></tr><tr><td><i>VTRNA1-2</i></td><td>vault RNA 1-2</td><td>2.28</td><td>0.026</td></tr><tr><td><i>PGF</i></td><td>Placenta growth factor</td><td>0.70</td><td>0.013</td></tr><tr><td><i>RNH1</i></td><td>ribonuclease/angiogen... | <table><tr><td>Gene symbol</td><td>Gene title</td><td>log2 fold change</td><td>P-value</td></tr><tr><td>VTRNA1-2</td><td>vault RNA 1-2</td><td>2.28</td><td>0.026</td></tr><tr><td>PGF</td><td>Placenta growth factor</td><td>0.70</td><td>0.013</td></tr><tr><td>RNH1</td><td>ribonuclease/angiogenin inhibitor 1</td><td>0.57<... | <table><tr><td>12A</td><td>ibitor) subunit 12A</td><td>.88</td><td>021</td></tr><tr><td>FNBP1L</td><td>formin binding protein 1-like</td><td>−0.89</td><td>0.046</td></tr><tr><td>SMC6</td><td>structural maintenance of chromosomes 6</td><td>−0.92</td><td>0.026</td></tr><tr><td>SMC4</td><td>structural maintenance of chrom... |
8e7803222395a248696ed391dc85fd56c29843770de96edac2003224e13d780c.png | simple | <table><tr><td>Assembly</td><td>Dz (nm)</td><td>ζ (mV)</td><td>P</td><td>References</td></tr><tr><td>DODAB BF</td><td>59 ± 1</td><td>43 ± 2</td><td>0.215 ± 0.006</td><td>[24]</td></tr><tr><td>DODAB BF</td><td>55 ± 1</td><td>36 ± 2</td><td>0.248 ± 0.004</td><td>This work</td></tr><tr><... | <table><tr><td>Assembly</td><td>Dz (nm)</td><td>ζ (mV)</td><td>P</td><td>References</td></tr><tr><td>DODAB BF</td><td>59 ± 1</td><td>43 ± 2</td><td>0.215 ± 0.006</td><td>[24]</td></tr></table> | <table><tr><td>DODAB BF</td><td>55 ± 1</td><td>36 ± 2</td><td>0.248 ± 0.004</td><td>This work</td></tr><tr><td>DODAB BF/Gr</td><td>54 ± 1</td><td>72 ± 4</td><td>0.277 ± 0.004</td><td>[24]</td></tr><tr><td>DODAB BF/Gr</td><td>71 ± 1</td><td>58 ± 2</td><td>0.261 ± 0.003</td><td>This work</td></tr><tr><td>PSS</td><td>137 ... |
17a9cb2560756208243e9ba831043aa479e0ae1201831b33457386cc1394c08b.png | simple | <table><tr><td> </td><td>Study sample</td><td> </td><td>All first-time fathers in Norway*</td><td> </td><td> </td></tr><tr><td> </td><td>n</td><td>%</td><td>n</td><td>%</td><td>p-value**</td></tr><tr><td>Age groups</td><td> </td><td> </td><td> </td><td> </td><td><0.001</td></tr><tr><td>25-34 years</td><td>11 363</td... | <table><tr><td></td><td>Study sample</td><td></td><td>All first-time fathers in Norway*</td><td></td><td></td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>p-value**</td></tr><tr><td>Age groups</td><td></td><td></td><td></td><td></td><td><0.001</td></tr></table> | <table><tr><td>25-34 years</td><td>11 363</td><td>76.6</td><td>163 063</td><td>77.0</td><td></td></tr><tr><td>35-39 years</td><td>2 693</td><td>18.2</td><td>34 291</td><td>16.2</td><td></td></tr><tr><td>≥40 years</td><td>776</td><td>5.2</td><td>14 408</td><td>6.8</td><td></td></tr><tr><td>Mother tongue other than Norwe... |
3fb76f9383f7a41b708f7f6380149a43b4215acd10be29af312cbb9d3bf22e74.png | simple | <table><tr><td></td><td></td><td></td><td></td><td><i>p</i>-value<sup>+</sup></td></tr><tr><td></td><td>CONV</td><td>UTR</td><td>UCR</td><td>Overall</td></tr><tr><td>N participants with dry weight reduction</td><td>12</td><td>17</td><td>14</td><td></td></tr><tr><td>DBP-pre: BCM Measurement [mmHg]</td><td>74 ± 15</... | <table><tr><td></td><td></td><td></td><td></td><td>p-va</td></tr></table> | <table><tr><td></td><td></td><td></td><td></td><td>lue+</td></tr><tr><td></td><td>CONV</td><td>UTR</td><td>UCR</td><td>Overall</td></tr><tr><td>N participants with dry weight reduction</td><td>12</td><td>17</td><td>14</td><td></td></tr><tr><td>DBP-pre: BCM Measurement [mmHg]</td><td>74 ± 15</td><td>67 ± 13</td><td>76 ±... |
40060be7b0f3f5e2bb54af9e14a70c38eef1e43f403c2979c82608b1ca9a927a.png | complex | <table><tr><td></td><td colspan="2">1-factor solution*</td><td colspan="3">2-factor solution*</td><td colspan="4">3-factor solution*</td></tr><tr><td></td><td>loading</td><td>(residual variance)</td><td colspan="2">loading</td><td>(residual variance)</td><td colspan="3">loading</td><td>(residual variance)</td></tr><tr>... | <table><tr><td></td><td colspan="2">1-factor solution*</td><td colspan="3">2-factor solution*</td><td colspan="4">3-factor solution*</td></tr><tr><td></td><td>loading</td><td>(residual variance)</td><td colspan="2">loading</td><td>(residual variance)</td><td colspan="3">loading</td><td>(residual variance)</td></tr><tr>... | <table><tr><td>Distance tohealth services</td><td>0.896</td><td>(0.197)</td><td>-0.017</td><td>0.967</td><td>(0.083)</td><td>0.987</td><td>-0.025</td><td>-0.002</td><td>(0.044)</td></tr><tr><td>Having to taketransportation</td><td>0.876</td><td>(0.233)</td><td>0.027</td><td>0.883</td><td>(0.194)</td><td>0.859</td><td>0... |
3c2eba5a0be6f8f6e706f7bec1977f8a57156268f42d40eb1456a1a6ccc5d513.png | simple | <table><tr><td>Health Care Organisation Chart</td></tr><tr><td>Processes Maps</td></tr><tr><td>Procedures for risk classification and reduction</td></tr><tr><td>Procedures and Formal Documents (i.e. budgeting, meeting minutes, etc.)</td></tr><tr><td>Documents of Reform Projects</td></tr><tr><td>Periodic Education Plan<... | <table><tr><td>Health Care Organisation Chart</td></tr><tr><td>Processes Maps</td></tr><tr><td>Procedures for risk classification and reduction</td></tr><tr><td>Procedures and Formal Documents (i.e. budgeting, meeting minutes, etc.)</td></tr><tr><td>Documents of Reform Projects</td></tr><tr><td>Periodic Education Plan<... | <table><tr><td>Clinical Care Pathways</td></tr><tr><td>Clinical Records</td></tr><tr><td>Operating Theatres Registries</td></tr><tr><td>Performance Measurement or Appraisal Tools and Procedures</td></tr><tr><td>Health Care Professionals Evaluation Forms</td></tr><tr><td>HTA Tools and Procedures</td></tr><tr><td>Procedu... |
7983f323794c3721354479bd626e40fb044b80f4b817fd218aefd7970de6c787.png | simple | <table><tr><td>Power Level</td><td>TXCTRL Register</td><td>Output Power</td><td>Current Consumption</td></tr><tr><td>31</td><td>0xA0FF</td><td>0 dBm</td><td>17.4 mA</td></tr><tr><td>27</td><td>0xA0FB</td><td>−1 dBm</td><td>16.5 mA</td></tr><tr><td>23</td><td>0xA0F7</td><td>−3 dBm</td><td>15.2 mA</td></tr><t... | <table><tr><td>Power Level</td><td>TXCTRL Register</td><td>Output Power</td><td>Current Consumption</td></tr><tr><td>31</td><td>0xA0FF</td><td>0 dBm</td><td>17.4 mA</td></tr><tr><td>27</td><td>0xA0FB</td><td>−1 dBm</td><td>16.5 mA</td></tr><tr><td>23</td><td>0xA0F7</td><td>−3 dBm</td><td>15.2 mA</td></tr><tr><td>19</td... | <table><tr><td>Power Level</td><td>TXCTRL Register</td><td>Output Power</td><td>Current Consumption</td></tr><tr><td>15</td><td>0xA0EF</td><td>−7 dBm</td><td>12.5 mA</td></tr><tr><td>11</td><td>0xA0EB</td><td>−10 dBm</td><td>11.2 mA</td></tr><tr><td>7</td><td>0xA0E7</td><td>−15 dBm</td><td>9.9 mA</td></tr><tr><td>3</td... |
dbf574e581fe743a89262f7300ac5f10cc636e79be6f84e1c20e219af67a9ee8.png | complex | <table><tr><td></td><td>Weeks of training (<i>n</i>)</td><td>Sessions/week (<i>n</i>)</td><td>MCT/session (min)</td><td>MCT/week (min)</td></tr><tr><td rowspan="3">ES</td><td>3</td><td>2</td><td>6</td><td>36</td></tr><tr><td rowspan="2">6</td><td rowspan="2">3</td><td>6</td><td>108</td></tr><tr><td>Total MCT</td><td>14... | <table><tr><td></td><td>Weeks of training (n)</td><td>Sessions/week (n)</td><td>MCT/session (min)</td><td>MCT/week (min)</td></tr><tr><td rowspan="2">ES</td><td>3</td><td>2</td><td>6</td><td>36</td></tr><tr><td>6</td><td>3</td><td>6</td><td>108</td></tr></table> | <table><tr><td></td><td>Weeks of training (n)</td><td>Sessions/week (n)</td><td>MCT/session (min)</td><td>MCT/week (min)</td></tr><tr><td>ES</td><td>6</td><td>3</td><td>Total MCT</td><td>144</td></tr><tr><td rowspan="3">LP</td><td>3</td><td>2</td><td>2</td><td>12</td></tr><tr><td rowspan="2">6</td><td rowspan="2">3</td... |
77be1612aa96a84422b2ace84385bc7571766add05b718e488f9e198dc289d6b.png | simple | <table><tr><td>Algorithm</td><td>Average CPU Estimation Time (ms)</td></tr><tr><td>ML-RL-DR</td><td>631.9</td></tr><tr><td>ML-RL-SDR</td><td>235.6</td></tr><tr><td>MM-RL-DR</td><td>368.8</td></tr><tr><td>MM-RL-SDR</td><td>243.9</td></tr><tr><td>WLS</td><td>6.8</td></tr><tr><td>ML-JE-Wang</td><td>245.0</td></tr><tr><td>... | <table><tr><td>Algorithm</td><td>Average CPU Estimation Time (ms)</td></tr><tr><td>ML-RL-DR</td><td>631.9</td></tr><tr><td>ML-RL-SDR</td><td>235.6</td></tr><tr><td>MM-RL-DR</td><td>368.8</td></tr><tr><td>MM-RL-SDR</td><td>243.9</td></tr><tr><td>WLS</td><td>6.8</td></tr></table> | <table><tr><td>Algorithm</td><td>Average CPU Estimation Time (ms)</td></tr><tr><td>ML-JE-Wang</td><td>245.0</td></tr><tr><td>MM-JE-Wang</td><td>295.9</td></tr></table> |
ebca4c2eaab384e3401c74b0ce16c7a0f4f90eb42f1ea394b9c50946de8f1020.png | simple | <table><tr><td>GEnt</td><td>Evolutionary tracea</td><td>Jensen–Shannon divergence</td><td>Property entropy</td><td>VN entropy</td><td>Relative entropy</td><td>Shannon entropy</td><td>Sum of pairs</td></tr><tr><td>142</td><td>142</td><td>184</td><td>173</td><td>125</td><td>168</td><td>171</td><td>184</td></tr><tr>... | <table><tr><td>GEnt</td><td>Evolutionary tracea</td><td>Jensen–Shannon divergence</td><td>Property entropy</td><td>VN entropy</td><td>Relative entropy</td><td>Shannon entropy</td><td>Sum of pairs</td></tr><tr><td>142</td><td>142</td><td>184</td><td>173</td><td>125</td><td>168</td><td>171</td><td>184</td></tr><tr><td>16... | <table><tr><td></td><td></td><td></td><td>351</td><td>353</td><td></td><td>351</td><td></td></tr><tr><td></td><td></td><td></td><td>353</td><td>354</td><td></td><td>353</td><td></td></tr><tr><td></td><td></td><td></td><td>354</td><td>365</td><td></td><td>354</td><td></td></tr><tr><td></td><td></td><td></td><td>365</td>... |
b4ab3c741b554bf68e72b6d43fb289b05b9a6b8569c29de75ac439767701e84e.png | simple | <table><tr><td>Species (Classification) No. of genomes analyzed</td><td>Genome size (mb)</td><td>Habitat niche</td><td>Disease</td><td>References</td></tr><tr><td><i>Neisseria meningitidis</i> (<i>Betaproteobacteria</i>) 5</td><td>2.2</td><td>Upper airway colonizer</td><td>Meningitis, septicemia, Waterhouse–Fride... | <table><tr><td>Species (Classification) No. of genomes analyzed</td><td>Genome size (mb)</td><td>Habitat niche</td><td>Disease</td><td>References</td></tr><tr><td>Neisseria meningitidis (Betaproteobacteria) 5</td><td>2.2</td><td>Upper airway colonizer</td><td>Meningitis, septicemia, Waterhouse–Friderichsen syndrome</td... | <table><tr><td>Bacillus subtilis (Bacilli) 1</td><td>4.2</td><td>Soil</td><td>Reference bacterium</td><td>Kunst et al. (1997)</td></tr><tr><td>Escherichia coli (Gammaproteobacteria) 18</td><td>4.6+</td><td>Intestine, sewer</td><td>Reference bacterium</td><td>Blattner et al. (1997)</td></tr></table> |
a6d9a4b9d0b893b5ae9966b1d7d134fbdd1596daff16cae5ea962fc671da0361.png | complex | <table><tr><td>Session</td><td>Module/Topic</td><td>Content example</td></tr><tr><td rowspan="3">1. Baseline</td><td>Blood Pressure and Hypertension Definitions</td><td>"Hypertension" is the medical term for high blood pressure. A person with high blood pressure is sometimes described as "hypertensive."</td></tr><tr><t... | <table><tr><td>Session</td><td>Module/Topic</td><td>Content example</td></tr><tr><td rowspan="3">1. Baseline</td><td>Blood Pressure and Hypertension Definitions</td><td>"Hypertension" is the medical term for high blood pressure. A person with high blood pressure is sometimes described as "hypertensive."</td></tr><tr><t... | <table><tr><td>Session</td><td>Module/Topic</td><td>Content example</td></tr><tr><td rowspan="3">3. Thirty Day</td><td>Tobacco and Alcohol Use</td><td rowspan="2">If you drink more than moderate amounts of it, alcohol can actually raise blood pressure by several points. It can also reduce the effectiveness of high bloo... |
f34a4f50067e1e4bf5ea7a76a885761e98258205cf0e3ab6a808b86d99ef43eb.png | simple | <table><tr><td>BMI</td><td>20 ></td><td>20-24.9</td><td>25 - 29.9</td><td>30 - 34.9</td><td>35 <</td><td><i>P</i>-value of chi-square test</td></tr><tr><td>Preeclampsia</td><td>5</td><td>19</td><td>31</td><td>12</td><td>2</td><td>0.001**</td></tr><tr><td></td><td>3.9%</td><td>4.6%</td><td>8.7%</td><td>12.2%</td><... | <table><tr><td>BMI</td><td>20 ></td><td>20-24.9</td><td>25 - 29.9</td><td>30 - 34.9</td><td>35 <</td><td>P-value of chi-square test</td></tr><tr><td>Preeclampsia</td><td>5</td><td>19</td><td>31</td><td>12</td><td>2</td><td>0.001**</td></tr><tr><td></td><td>3.9%</td><td>4.6%</td><td>8.7%</td><td>12.2%</td><td>3.33%</td>... | <table><tr><td>BMI</td><td>20 ></td><td>20-24.9</td><td>25 - 29.9</td><td>30 - 34.9</td><td>35 <</td><td>P-value of chi-square test</td></tr><tr><td>Preterm delivery</td><td>2</td><td>9</td><td>16</td><td>6</td><td>1</td><td>0.037*</td></tr><tr><td></td><td>1.6%</td><td>22.2%</td><td>4.7%</td><td>6.1%</td><td>0%</td><t... |
26c7f74a508723e3623a4d9103505b73791476fb2bc593d4e20c7ef32fcb6dda.png | complex | <table><tr><td>Type of allergy</td><td>No. of studies</td><td>Overall accuracy (%)</td><td>Application</td><td>ANN</td><td>SVM</td><td>BN</td><td>FL</td></tr><tr><td rowspan="7">Asthma</td><td rowspan="7">18</td><td rowspan="7">82.44 ± 23.71</td><td>To classify exacerbations [10–14]</td><td>1</td><td>1</td><... | <table><tr><td>Type of allergy</td><td>No. of studies</td><td>Overall accuracy (%)</td><td>Application</td><td>ANN</td><td>SVM</td><td>BN</td><td>FL</td></tr><tr><td rowspan="4">Asthma</td><td rowspan="4">18</td><td rowspan="4">82.44 ± 23.71</td><td>To classify exacerbations [10–14]</td><td>1</td><td>1</td><td>2</td><t... | <table><tr><td>Type of allergy</td><td>No. of studies</td><td>Overall accuracy (%)</td><td>Application</td><td>ANN</td><td>SVM</td><td>BN</td><td>FL</td></tr><tr><td rowspan="3">Asthma</td><td rowspan="3">18</td><td rowspan="3">82.44 ± 23.71</td><td>To classify how manage their pathology [21]</td><td>1</td><td>–</td><t... |
f6e13db26ff023cef369e242d4f84c6e7ec5c211fd41e2bfe75cd73b0c3d64f9.png | simple | <table><tr><td> </td><td>Immediately pre coronary angiography</td><td>6 months after coronary angiogrpahy</td><td>P</td></tr><tr><td>Global EF (%)</td><td>43 ± 10</td><td>44 ± 8</td><td>p = NS</td></tr><tr><td>The size of infarct area (%)</td><td>32 ± 10</td><td>30 ± 10</td><td>p = NS</td></tr><tr><... | <table><tr><td></td><td>Immediately pre coronary angiography</td><td>6 months after coronary angiogrpahy</td><td>P</td></tr><tr><td></td><td>43 </td><td>44 ±</td><td>p =</td></tr></table> | <table><tr><td>Global EF (%)</td><td>± 10</td><td> 8</td><td> NS</td></tr><tr><td>The size of infarct area (%)</td><td>32 ± 10</td><td>30 ± 10</td><td>p = NS</td></tr><tr><td>Infarct wall movement velocity (cm/s)</td><td>1.76 ± 0.76</td><td>1.80 ± 0.76</td><td>p = NS</td></tr><tr><td>End-diastolic volume (LVEDV) (ml)</... |
b73ffc352bf9617c61d35401f94d99bb8f1e97dbae8d8536a46bf9c9f627153b.png | simple | <table><tr><td>Rotated Component Matrix(a)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Verbal Learning & Memory</td><td>Processing Speed</td><td>Attention and Working Memory</td><td>Verbal Fluency and Naming</td><td>Concept Formation</td></tr><tr><td>Alpha</td><td>0.883</td><td>0.731</td>... | <table><tr><td>Rotated Component Matrix(a)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Verbal Learning & Memory</td><td>Processing Speed</td><td>Attention and Working Memory</td><td>Verbal Fluency and Naming</td><td>Concept Formation</td></tr><tr><td>Alpha</td><td>0.883</td><td>0.731</td><td>... | <table><tr><td>Word List Trial 2</td><td>67</td><td></td><td></td><td></td><td></td></tr><tr><td>Word Recognition</td><td>0.774</td><td></td><td></td><td></td><td></td></tr><tr><td>Word List Trial 3</td><td>0.792</td><td></td><td></td><td></td><td></td></tr><tr><td>Word List Cued Recall (Total)</td><td>0.829</td><td></... |
84ed3fc797946c83331a03fcd570aad179452bceab606f83b311562b06cfcfb1.png | complex | <table><tr><td></td><td colspan="3">Worry about infection of A/H1N1</td><td colspan="3">Take up preventive measures in daily life</td></tr><tr><td>Variables</td><td>Row%</td><td>OR<sub>u </sub>(95% CI)</td><td>OR<sub>m</sub>(95% CI)</td><td>Row%</td><td>OR<sub>u </sub>(95% CI)</td><td>OR<sub>m</sub>(95% CI)</td></tr><t... | <table><tr><td></td><td colspan="3">Worry about infection of A/H1N1</td><td colspan="3">Take up preventive measures in daily life</td></tr><tr><td>Variables</td><td>Row%</td><td>ORu (95% CI)</td><td>ORm(95% CI)</td><td>Row%</td><td>ORu (95% CI)</td><td>ORm(95% CI)</td></tr><tr><td>Know the main modes of transmission</t... | <table><tr><td>No</td><td>-</td><td>-</td><td>-</td><td>73.4</td><td>1.00</td><td>NS</td></tr><tr><td>Yes</td><td></td><td></td><td></td><td>87.2</td><td>2.47(2.22-2.76) †</td><td></td></tr></table> |
8afcb1e32c9427c007de2690825f61a11fb435d9fc038ca40ebc0a4931c6a3dd.png | complex | <table><tr><td>Predictor</td><td>B</td><td>SE B</td><td>β</td><td>R<sup>2</sup></td></tr><tr><td><i>Step 1</i></td><td></td><td></td><td></td><td>.05***</td></tr><tr><td>SES</td><td>.14</td><td>.03</td><td>.14***</td><td></td></tr><tr><td>City</td><td>.15</td><td>.04</td><td>.13***</td><td></td></tr><tr><td>5<sup>... | <table><tr><td>Predictor</td><td>B</td><td>SE B</td></tr><tr><td>Step 1</td><td></td><td></td></tr><tr><td>SES</td><td>.14</td><td>.03</td></tr><tr><td>City</td><td>.15</td><td>.04</td></tr><tr><td>5th grade</td><td>.08</td><td>.04</td></tr><tr><td>6th grade</td><td>.11</td><td>.04</td></tr><tr><td>Step 2</td><td></td>... | <table><tr><td>β</td><td>R2</td></tr><tr><td></td><td>.05***</td></tr><tr><td>.14***</td><td></td></tr><tr><td>.13***</td><td></td></tr><tr><td>.08*</td><td></td></tr><tr><td>.11***</td><td></td></tr><tr><td></td><td>.08***</td></tr><tr><td>-.08*</td><td></td></tr><tr><td>-.16***</td><td></td></tr><tr><td></td><td>.08*... |
7d63795bd41085b0d83040899787caa7afdf170fe05e1c738f28ce625190535d.png | simple | <table><tr><td>Subtype</td><td>Location</td></tr><tr><td>A</td><td>Pancreatic duct into parenchyma<sup><i>∗</i></sup></td></tr><tr><td>B</td><td>Pancreatic duct through parenchyma<sup><i>∗</i></sup></td></tr><tr><td>C</td><td>Intrahepatic bile ducts into parenchyma<sup><i>∗∗</i></sup></td></tr><... | <table><tr><td>Subty</td><td>Locati</td></tr></table> | <table><tr><td>pe</td><td>on</td></tr><tr><td>A</td><td>Pancreatic duct into parenchyma∗</td></tr><tr><td>B</td><td>Pancreatic duct through parenchyma∗</td></tr><tr><td>C</td><td>Intrahepatic bile ducts into parenchyma∗∗</td></tr><tr><td>D</td><td>Intrahepatic bile ducts through parenchyma∗∗∗</td></tr></table> |
aa2cce0765a66b7e1063491a9269702500a4fa950a4b64cc2163dd559aff576e.png | simple | <table><tr><td>Group</td><td>TAV (mm<sup>3</sup>)</td></tr><tr><td>BMP group</td><td>4.27 (3.08–18.23)</td></tr><tr><td> with pins (<i>n</i> = 2)</td><td>20.87 (19.55–22.20)</td></tr><tr><td> without pins (<i>n</i> = 3)</td><td>3.08 (1.68–3.68)</td></tr><tr><td>nonBMP group</td><td>6.24 (5.71–7.... | <table><tr><td>Group</td></tr><tr><td>BMP group</td></tr><tr><td>with pins (n = 2)</td></tr><tr><td>without pins (n = 3)</td></tr><tr><td>nonBMP group</td></tr><tr><td>with pins (n = 2)</td></tr><tr><td>without pins (n = 3)</td></tr><tr><td>Control group</td></tr></table> | <table><tr><td>TAV (mm3)</td></tr><tr><td>4.27 (3.08–18.23)</td></tr><tr><td>20.87 (19.55–22.20)</td></tr><tr><td>3.08 (1.68–3.68)</td></tr><tr><td>6.24 (5.71–7.52)</td></tr><tr><td>12.25 (9.88–14.62)</td></tr><tr><td>5.71 (3.15–5.98)</td></tr><tr><td>2.75 (1.98–4.80)</td></tr></table> |
bbfcd57f3841bb4ca65a796f4f68591e54d9914281fb4de1ee1d4964c7970bbd.png | simple | <table><tr><td>Group</td><td>Pretest</td><td>Posttest</td><td>Adjusted mean</td></tr><tr><td>Chess</td><td>1.75 (1.34)</td><td>1.81 (1.69)</td><td>1.64</td></tr><tr><td>Checkers</td><td>1.28 (0.96)</td><td>1.60 (1.14)</td><td>1.75</td></tr><tr><td>Control</td><td>1.41 (1.20)</td><td>1.87 (1.36)</td><td>1.83</td></tr></... | <table><tr><td>Group</td><td>Pretest</td><td>Posttest</td><td>Adjusted mean</td></tr><tr><td>Chess</td><td>1.75 (1.34)</td><td>1.81 (1.69)</td><td>1.64</td></tr></table> | <table><tr><td>Checkers</td><td>1.28 (0.96)</td><td>1.60 (1.14)</td><td>1.75</td></tr><tr><td>Control</td><td>1.41 (1.20)</td><td>1.87 (1.36)</td><td>1.83</td></tr></table> |
4728d823e7b70fba6ce28af97733b44ffd4575261956b7577a278898ed3359f1.png | simple | <table><tr><td>Haplotype</td><td>Frequencies</td><td>Patients/Deaths</td><td>HR (95% CI) <sup>a</sup></td></tr><tr><td>TTGG</td><td>0.415</td><td>379/184</td><td>1.00</td></tr><tr><td>CTGA</td><td>0.408</td><td>373/170</td><td>0.90 (0.73–1.10)</td></tr><tr><td>CCAA</td><td>0.079</td><td>72/30</td><td>0.79 (0.54&#... | <table><tr><td>Haplotype</td><td>Frequencies</td><td>Patients/Deaths</td><td>HR (95% CI) a</td></tr><tr><td>TTGG</td><td>0.415</td><td>379/184</td><td>1.00</td></tr><tr><td>CTGA</td><td>0.408</td><td>373/170</td><td>0.90 (0.73–1.10)</td></tr></table> | <table><tr><td>CCAA</td><td>0.079</td><td>72/30</td><td>0.79 (0.54–1.17)</td></tr><tr><td>TTGA</td><td>0.036</td><td>33//11</td><td>0.54 (0.30–1.00)</td></tr><tr><td>CTAA</td><td>0.024</td><td>22//6</td><td>0.47 (0.21–1.07)</td></tr><tr><td>CTGG</td><td>0.015</td><td>14//10</td><td>1.55 (0.81–2.94)</td></tr></table> |
70483333b17bd25e3e6b89204dd23a144b034b8c0b7b04ba5f6589bceb3ee5cb.png | simple | <table><tr><td>Characteristic</td><td>MetS present N = 73</td><td>MetS absent N = 93</td><td><i>P</i>-value adjusted for age and sex</td></tr><tr><td>age (years)</td><td>42.2 ± 1.6</td><td>34.8 ± 1.6</td><td>0.0019</td></tr><tr><td>male (%)</td><td>35.6</td><td>43.0</td><td>NS (0.33)</td></tr><tr><td>current ... | <table><tr><td>Characteristic</td></tr><tr><td>age (years)</td></tr><tr><td>male (%)</td></tr><tr><td>current smokers (%)</td></tr><tr><td>BMI (kg/m2)</td></tr><tr><td>waist (cm)</td></tr><tr><td>hypertensive (%)</td></tr><tr><td>antihypertensive treatment (%)</td></tr><tr><td>total cholesterol (mmol/L)</td></tr><tr><t... | <table><tr><td>MetS present N = 73</td><td>MetS absent N = 93</td><td>P-value adjusted for age and sex</td></tr><tr><td>42.2 ± 1.6</td><td>34.8 ± 1.6</td><td>0.0019</td></tr><tr><td>35.6</td><td>43.0</td><td>NS (0.33)</td></tr><tr><td>13.9*</td><td>16.3†</td><td>NS (0.86)</td></tr><tr><td>31.3 ± 0.5</td><td>27.4 ± 0.5<... |
1b75772ba9f0e9fe91d248c1f6ab4e531ba6218bf10ba30a041886ffc890fcf8.png | simple | <table><tr><td></td><td>Cross-sectional</td><td></td><td>Longitudinal</td><td></td></tr><tr><td></td><td>Overweight T1</td><td>School Sample</td><td>Overweight T1</td><td>Overweight T2</td></tr><tr><td>n</td><td>125</td><td>172</td><td>80</td><td>80</td></tr><tr><td>Age</td><td>6–16</td><td>7–17</td><td>6&#... | <table><tr><td></td><td>Cross-sectional</td><td></td><td>Longitudinal</td><td></td></tr><tr><td></td><td>Overweight T1</td><td>School Sample</td><td>Overweight T1</td><td>Overweight T2</td></tr><tr><td>n</td><td>125</td><td>172</td><td>80</td><td>80</td></tr></table> | <table><tr><td>Age</td><td>6–16</td><td>7–17</td><td>6–16</td><td>7–18</td></tr><tr><td></td><td>11.02 (SD = 2.41)</td><td>11.88 (SD = 2.45)</td><td>11.29 (SD = 2.29)</td><td>12.58 (SD = 2.26)</td></tr><tr><td>Sex</td><td>61 female</td><td>88 female</td><td>42 female</td><td>42 female</td></tr><tr><td></td><td>64 male<... |
bb5858e4762d3fa59afa0e088c86729ee1e49d77882c42d421f09424269e60d5.png | simple | <table><tr><td></td><td>Wild type</td><td>CD4<sup>−/−</sup></td></tr><tr><td>Eosinophilia(cells/mg of lung tissue) (as % of total white cells)</td><td>684 ± 132 (6.3 %)</td><td>648 ± 161 (4.3 %)</td></tr><tr><td>Neutrophilia(cells/mg of lung tissue) (as % of total white cells)</td><td>6443 ± ... | <table><tr><td></td><td>Wild type</td><td>CD4−/−</td></tr><tr><td>Eosinophilia(cells/mg of lung tissue) (as % of total white cells)</td><td>684 ± 132 (6.3 %)</td><td>648 ± 161 (4.3 %)</td></tr><tr><td>Neutrophilia(cells/mg of lung tiss</td><td>6443 ± 1048</td><td>7361 ± 2260 (49.1</td></tr></table> | <table><tr><td>ue) (as % of total white cells)</td><td> (45.3 %)</td><td> %)</td></tr><tr><td>Tissue mono/macs(cells/mg of lung tissue) (as % of total white cells)</td><td>639 ± 132 (4.5 %)</td><td>686 ± 179 (9.4 %)</td></tr><tr><td>Alveolar macs(cells/mg of lung tissue) (as % of total white cells)</td><td>292 ± 48 (2.... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.